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ABSTRACT 
Although hypoxia is a major stress on physiological processes, several human populations have 
survived for millennia at high altitudes, suggesting that they have adapted to hypoxic conditions. This 
hypothesis was recently corroborated by studies of Tibetan highlanders, which showed that 
polymorphisms in candidate genes show signatures of natural selection as well as well-replicated 
association signals for variation in hemoglobin levels. We extended genomic analysis to two Ethiopian 
ethnic groups: Amhara and Oromo. For each ethnic group, we sampled low and high altitude residents, 
thus allowing genetic and phenotypic comparisons across altitudes and across ethnic groups. Genome-
wide SNP genotype data were collected in these samples by using Illumina arrays. We find that variants 
associated with hemoglobin variation among Tibetans or other variants at the same loci do not influence 
the trait in Ethiopians. However, in the Amhara, SNP rs10803083 is associated with hemoglobin levels 
at genome-wide levels of significance. No significant genotype association was observed for oxygen 
saturation levels in either ethnic group. Approaches based on allele frequency divergence did not detect 
outliers in candidate hypoxia genes, but the most differentiated variants between high- and lowlanders 
have a clear role in pathogen defense. Interestingly, a significant excess of allele frequency divergence 
was consistently detected for genes involved in cell cycle control, DNA damage and repair, thus 
pointing to new pathways for high altitude adaptations. Finally, a comparison of CpG methylation levels 
between high- and lowlanders found several significant signals at individual genes in the Oromo.  
AUTHOR SUMMARY 
Although hypoxia is a major stress on physiological processes, several human populations have 
survived for millennia at high altitudes, suggesting that they have adapted to hypoxic conditions. 
Consistent with this idea, previous studies have identified genetic variants in Tibetan highlanders 
associated with reduction in hemoglobin levels, an advantageous phenotype at high altitude. To compare 
the genetic bases of adaptations to high altitude, we collected genetic and epigenetic data in Ethiopians 
living at high and low altitude, respectively. We find that variants associated with hemoglobin variation 
among Tibetans or other variants at the same loci do not influence the trait in Ethiopians. However, we 
find a different variant that is significantly associated with hemoglobin levels in Ethiopians. Approaches 
based on the difference in allele frequency between high- and lowlanders detected strong signals in 
genes with a clear role in defense from pathogens, consistent with known differences in pathogens 
between altitudes. Finally, we found a few genome-wide significant epigenetic differences between 
altitudes. These results taken together imply that Ethiopian and Tibetan highlanders adapted to the same 
environmental stress through different variants and genetic loci. 
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INTRODUCTION  
Hypoxia is a major stress on human physiological processes and a powerful homeostasis system 
has evolved in animals to cope with fluctuations in oxygen concentration [1]. High altitude (HA) 
hypoxia, such as that experienced at 2500m of altitude or greater, engages this system and elicits 
physiological acclimatization when lowlanders become exposed to hypoxia. In addition to lower oxygen 
levels, lower biodiversity and extreme day-to-night temperature oscillations challenge HA living. The 
classic response is an increase in hemoglobin (Hb) concentration that during acclimatization 
compensates for the unavoidable lowered percent of oxygen saturation (O2 sat) of Hb due to ambient 
hypoxia. Acclimatization is not completely effective, however. For example, birth weights are lower 
than at low altitude (LA) as is physical exercise performance [2,3]. In addition, lowlanders residing at 
altitudes higher than 2500 meters (m) are at risk for chronic health problems arising in part from 
acclimatization processes. For example, long-term high Hb levels increase blood viscosity as well as the 
risk of thrombosis and stroke [4,5,6] and poorer pregnancy outcomes [7]. These results taken together 
suggest that the acclimatization response does not assure that fitness is unaltered at HA. Several 
distantly related human populations have survived for 5-50 thousand years (ky) [8,9,10] at altitudes 
above 2500 m. Indeed, in most cases, sufficient time has elapsed since HA settlement for natural 
selection to have changed the frequency of adaptive alleles. Interestingly, even though all HA residents 
are exposed to the same, constant, ambient hypoxia, indigenous highlander populations show distinctive 
physiological characteristics thought to offset HA stress: Andeans show some reduction in O2 sat, but a 
marked increase in Hb levels [11], Tibetans present markedly low O2 sat, but relatively little increase in 
Hb levels [12], and Amhara in Ethiopia present little reduction in O2 sat or increase in Hb levels [13,14]. 
Whether these phenotypic contrasts reflect different genetic adaptations across populations remains an 
open question. 
Substantial evidence in Tibetan highlanders suggests that variation in Hb levels and O2 sat is 
adaptive. In the Tibetan population, a major gene effect on O2 sat was detected, with the inferred 
genotypes associated with higher O2 sat also associated with higher reproductive success [15]; though 
the locus underlying this effect has not yet been identified, its effect on phenotypes directly related to 
fitness points to the presence of adaptive variation. With regard to Hb levels, which are surprisingly 
similar between Tibetan highlanders and lowlanders at sea level [11], population genetics and genotype-
phenotype association analyses have identified alleles at two loci (endothelial PAS domain protein 1 
(EPAS1) and egl nine homolog 1 (EGLN1)) that are consistently associated with signatures of positive 
natural selection and with lower Hb levels, suggesting that natural selection in Tibet favored variants 
that counteract the deleterious effects of long-term acclimatization [16,17,18,19]. 
An analysis of genome-wide genotype data in Tibetan and Andean highlanders suggested that 
natural selection acted on largely distinct loci in the two populations [20]. In addition, a recent study 
comparing Ethiopian Amhara highlanders with other ethnic groups at LA identified yet another set of 
candidate targets of selection [21]. However, the Tibetans remain unique with regard to the strength of 
the evidence for natural selection and the marked genetic effects on the Hb level phenotype. 
HA populations offer a rare opportunity to investigate the impact of natural selection on the 
genetic architecture of adaptation because independent realizations of the adaptive process can be 
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examined in different parts of the world. Specifically, the Ethiopian highlands offer a unique opportunity 
to study HA adaptation because individuals from distinct, but closely related ethnic groups have 
communities at HA and LA, thus allowing more informative genetic and phenotypic comparisons. In 
this study, we extended genomic analysis to two Ethiopian ethnic groups, Amhara and Oromo, with the 
goal of determining whether Tibetans and Ethiopian highlanders share the same adaptations and of 
elucidating the genetic bases of adaptive HA phenotypes in Ethiopia. We also measured genome-wide 
methylation levels to explore the contribution of epigenetic modifications to HA adaptations. 
 
RESULTS 
The Ethiopian Amhara and Oromo differ in adaptive phenotypes 
We obtained phenotype data in two distinct, but closely related ethnic groups, the Amhara and 
the Oromo (Texts S1-S2; Figures S1-S5), that include communities of HA and LA residents. All 
individuals were born and raised at the same altitude where they were sampled. These samples allow 
comparing phenotypes across altitudes within ethnic groups as well as across ethnic groups. While 
historical records indicate that the Oromo have moved to HA only in the early 1500s [22,23], the 
Amhara have inhabited altitudes above 2500m for at least 5ky and altitudes around 2300-2400m for 
more than 70ky [24,25]. Therefore, sufficient time has elapsed for the Amhara to have evolved genetic 
adaptations to hypoxia.  
As shown in Figure 1, the HA samples of both ethnic groups had higher Hb than the LA samples, 
however the Oromo had twice as much elevation in Hb as the Amhara. The elevation in Hb levels is 
particularly evident for the measurements in males, raising the possibility that other factors (e.g. 
menstrual cycle) in females affect the power to detect significant phenotypic differences between 
groups. With regard to O2 sat, HA Amhara had a 5.6% lower O2 sat compared to LA Amhara while HA 
Oromo had 10.5% lower O2 sat than their LA counterparts. Therefore, we detected significant 
phenotypic differences not only between populations from the same ethnic group that live at different 
altitudes, but also across populations from closely related ethnic groups (Oromo and Amhara) that live at 
the same altitude. Given the low genetic divergence between these two ethnic groups at the genome-
wide level (mean FST
 
= 0.0098), the phenotypic differences between Amhara and Oromo highlanders are 
unlikely to be due to independent genetic adaptations in these ethnic groups; rather they are likely to 
reflect genetic adaptations that evolved in the Amhara, due to their longer residence at HA.  
We also measured pulse and calculated arterial oxygen content, but these phenotypes did not 
show significant differences across ethnic groups or altitudes and were omitted from further analyses. 
For details on the phenotypic variation in Amhara and Oromo, see Text S3, Tables S1-S2 and Figure S6. 
 
Genome-wide association signals in Ethiopia 
To learn about the genetic bases of variation in Hb level and O2 sat in Ethiopia, we tested for an 
association between SNP genotype in the 260 unrelated Ethiopian samples and Hb levels or O2 sat. We 
considered the total Ethiopian sample (i.e. HA and LA Amhara and Oromo) as well as each ethnic group 
and each altitude separately (Figures S7-S15). No genome-wide significant signal was observed for 
either Hb levels or O2 sat in the Oromo and in the total Ethiopian sample and for O2 sat in the Amhara 
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(Figures S7-S15 and Tables S3-S20). Likewise, no excess of low p-values was observed in these 
association analyses relative to null expectations obtained by permutations (Figures S7-S15). In contrast, 
the Amhara showed an excess of low association p-values in the analysis of Hb levels compared to 
expectations obtained by permutations (Figure 2A), indicating a genetic contribution to variation in Hb 
levels. In addition, one SNP (rs10803083) on chromosome 1 was associated with variation in Hb levels 
(p= 4.96x10
-8
) in Amhara; this association is genome-wide significant after correction for the 985,385 
tests performed (Figure 2B and Table S3). In addition, the next six most strongly associated SNPs are in 
strong LD with rs10803083 (r
2≥0.69).  There are no known genes within 600kb of these SNPs, and the 
closest genes, i.e. phospholipase D family member 5 (PLD5) and centrosomal protein 170kDa 
(CEP170), are not obvious candidate genes for variation in Hb levels. These SNPs do not reside within 
an ultra conserved sequence element. Notably, the effect size of SNP rs10803083 (~0.83 g/dL, Figure 
2C) is half that of the EGLN1 SNPs [16] but comparable to that of Hb associated EPAS1 SNPs in 
Tibetans [17]. Although SNP rs10803083 reaches genome-wide significance levels, replication studies 
will be needed to further assess the evidence for an association with Hb levels.  
Our sample size is small relative to traditional GWAS, thus liming the power of our analysis. In 
addition, due to the correlation between linked SNPs, the Bonferroni correction we applied is overly 
conservative. Therefore, many true Hb concentration variants may not reach genome-wide levels of 
significance. In this regard, it is interesting to note that the second strongest association signal 
(rs2899662) is located within the established hypoxia-candidate gene retinoid-related orphan receptor 
alpha (RORA). RORA encodes a protein that induces the transcriptional activation of hypoxia-inducible-
factor-1alpha (HIF-1α) [26], thus it plays a significant role in the same pathway where adaptations were 
detected in Tibetans. This SNP is, therefore, an excellent candidate for variation in Hb levels. Additional 
SNPs of interest for follow up analyses (Table S3) include: the solute carrier family 30 member 9 
(SLC30A9), which is regulated by hypoxia [27], the collagen type VI alpha 1 (COL6A1), which is 
associated with performance during endurance cycling [28] and is a HIF response gene [29], and the 
hepatocyte growth factor (HGF), which is induced by hypoxia [30], activates HIF1 DNA binding [31], 
plays a role in angiogenesis and protects against hypoxia induced cell injury [32,33].  
 
Comparing the genetic architecture of Hb levels between Ethiopians and Tibetans 
The above association analyses allow comparing the genetic architecture of Hb levels between 
Ethiopians and Tibetans [16,17,18].  
First, we focused on the EPAS1 and EGLN1 SNPs that were previously associated with variation 
in Hb levels in Tibetans, with effect sizes of 0.8 g/dL and 1.7 g/dL, respectively [16,17]. None of these 
SNPs were significantly associated with Hb levels in Ethiopians (Table 1). Because we have complete or 
nearly complete power to detect a genotype-phenotype association in our Ethiopian samples (see Text 
S4 and Table S21), we infer that the SNPs associated with variation in Hb levels in the Tibetans do not 
make a contribution in Ethiopians. 
Second, because the association signal in the Tibetans may be due to an untyped variant that is 
tagged by different SNPs in Tibetans and Ethiopians, we also considered all SNPs within 10kb of the 
EPAS1 and the EGLN1 genes and repeated this analysis applying a Bonferroni correction for the number 
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of tests performed. None of the EPAS1 or EGLN1 SNPs was significantly associated with Hb levels in 
Ethiopians. Based on power analyses (Figure 3), we can exclude associated variants with the same effect 
size as in Tibetans if the MAF in Ethiopia is greater than 10% and 5%, respectively, for the EPAS1 and 
EGLN1 genes (see Figure S16 for Amhara and Oromo). Therefore, this more comprehensive analysis 
suggests that genes shown to contribute to variation in Hb levels in Tibetans either do not influence 
variation in the Ethiopian populations or if they do, their effect sizes are lower than those reported for 
the Tibetans. 
Third, we considered all SNPs within 10kb of the candidate genes in the “Response to Hypoxia” 
Gene Ontology (GO) category (26 genes). None of these SNPs is significantly associated with Hb levels 
after multiple test correction (p < 0.05/1309 = 3.81x10
-5
). Because of the larger number of SNPs tested, 
this analysis has a relatively high multiple testing burden. Nonetheless, we find that we have greater than 
80% power to detect a SNP significantly associated with Hb levels and effect size 0.8g/dL if its MAF is 
at least 20% and 100% power if its effect size is 1.7g/dL Hb (Figure 3C and Figure S16 for Oromo and 
Amhara). Therefore, we conclude that variation within the “Response to Hypoxia” GO category genes is 
unlikely to have the same effect on Hb levels in Ethiopians as that observed in Tibetans. 
 
Assessing genetic differences between high and low altitude populations 
A widely used family of approaches for the detection of beneficial alleles uses information about 
the haplotype structure around the selected site [34,35]. However, these approaches have adequate 
power only in the case of new advantageous alleles that were driven to high frequency by natural 
selection, i.e. ≥70% [34,36]. Because the largest allele frequency differences observed between HA and 
LA among Amhara or Oromo is less than 40%, these approaches are unlikely to be powerful in this 
setting. Therefore, to identify alleles that contribute to genetic adaptations to HA in Ethiopians, we used 
two complementary approaches that focus on the divergence of allele frequency between HA and LA 
populations. One of these approaches was previously used to successfully identify adaptive alleles in 
Tibetan highlanders [18]. 
The first approach is based on the population branch statistic (PBS) [18], which summarizes 
information about the allele frequency change (PBSA_BC) at a given locus in the history of a population 
(population A) since its divergence from two populations (population B and C) so that a high PBSA_BC 
value represents a marked change in allele frequency on the branch leading to population A. This 
approach was previously used to detect advantageous alleles in Tibetans relative to Han Chinese and 
Europeans [18]. We tested for an excess of high allele frequency differentiation (i.e. large PBS values) 
on the branch leading to the Ethiopian populations in SNPs within candidate genes for response to 
hypoxia (i.e., genes within “Response to Hypoxia” GO category) relative to SNPs in all other genes 
(Table S22 lists all the population trios tested). Specifically, we calculated the ratio of the proportion of 
SNPs in hypoxia genes vs. the proportion of SNPs in all other genes in the top 0.5%, 1% and 5% of the 
distribution of PBS values and used bootstrap resampling to assess the significance of the excess of large 
PBS values. Although an excess was observed in most population trios (Table S22), this excess was 
rarely statistically significant; this finding suggests that levels of linkage disequilibrium in hypoxia 
genes tend to be higher than in other genes and that this feature may be a confounder in tests for 
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selection [18]. A significant excess of large PBS values in hypoxia genes was observed only in the HA 
Amhara and the entire Amhara sample (Table S22 and Figures S17A-B), thus suggesting that HA 
Amhara indeed evolved genetic adaptations to hypoxic environments. When we extended this analysis 
of these same population trios to additional gene classifications (i.e. BioCarta, KEGG, Gene Ontology), 
we found significant enrichments for SNPs in gene sets related to cell cycle control, response to DNA 
damage and DNA repair (Table 2).  
Interestingly, however, the SNPs with the highest PBS values are found in genes with a well-
established role in pathogen response (Table S23-S24). More specifically, the SNPs with the highest 
PBS values are located within the major histocompatibility complex class II DR alpha (HLA-DRA). 
Moreover, the null allele (FY*0) at the Duffy blood group locus, which protects against Plasmodium 
vivax malaria [37] and predicts white blood cell and neutrophil counts [38], has the second highest 
value. Consistent with expectations based on the protective effects of the FY*0 allele against malaria, its 
frequency is lower at HA compared to LA, where malaria is endemic (51.5% vs. 74.1%). Therefore, 
these results suggest that, in Ethiopian populations, differences in pathogen loads between LA and HA 
environments result in stronger selective pressures compared to differences in oxygen levels. 
SNPs with large, even though not extreme PBS scores and lying within genes known to play an 
important role in hypoxia are of potential interest for follow up studies. These genes include: Cullin3 
(CUL3), which potentiates HIF-1 signaling [39], as well as adrenergic beta receptor kinase 1 (ADRBK1) 
[40], coronin actin binding protein 1B (CORO1B) [41], anti-silencing function 1 homolog B (ASF1B) 
[42] and MAPK-activated protein kinase MK2 (MAPKAPK2) [43], which are all down-regulated under 
hypoxia (Tables S23-24). None of those large PBS SNPs were significantly associated with Hb or O2 sat 
(Table S25-S26), but a SNP within utrophin A (UTRN) - rs7753021 - reached nominal levels of 
significance with O2 sat (p = 0.005; Tables S26). UTRN expression correlates with oxidative capacity 
[44] and increases with chronic physical training [45]. Slow-twitch muscles, which are associated with 
endurance performance, have high levels of UTRN [46]. 
In a complementary analysis, we developed a multiple regression (MR) approach to identify 
SNPs that show high allele frequency differentiation in HA populations relative to predictions based on 
a large set of worldwide population samples.  This method should also be able to predict allele 
frequencies appropriately in a situation where the target population is admixed. In this approach, we 
used allele frequency data from 61 LA populations (including the HGDP and several other populations) 
to predict the expected allele frequencies in the HA Amhara.  We focused on the HA Amhara because 
they have lived at HA for a longer period of time and exhibit distinct patterns of Hb and O2 sat levels 
compared to the Oromo (Figure 1). In addition, we omitted the LA Amhara in an attempt to reduce the 
effect of gene flow between altitudes, which could potentially reduce our power to detect adaptive 
divergence.  We used all SNPs to estimate the best-fitting regression coefficients for each population: 
that is, these are the coefficients that generate the lowest mean square error in predicting the HA Amhara 
allele frequencies.  The populations with the largest regression coefficients in the Amhara regression 
model are from geographically proximate populations in East Africa (Maasai, Luhya and LA Oromo) 
and from the Middle East and Southern Europe (see Figure S18).  We reasoned that changes in allele 
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frequencies due to high altitude adaptation would be detectable as departures (i.e. large residuals) from 
the predicted allele frequencies based on all other populations 
As for the PBS analysis, we tested for an excess of SNPs with high allele frequency 
differentiation using the MR statistic for genes within “Response to Hypoxia” GO category relative to 
SNPs in all other genes and we used a bootstrap procedure to assess the significance of the observed 
excess. An excess was observed for all tail cut-offs, but only one reached statistical significance (Table 
2). Other gene sets that showed a significant enrichment of SNPs with strong MR signals include 
chromosome organization and biogenesis, DNA repair, histone modification. These findings are 
consistent with the pattern observed in the PBS analysis, indicating that they are robust to the choice of 
populations used in the test (Table 2). 
Among the SNPs with the largest MR scores, there are several SNPs in hypoxia genes, which 
may be of potential interest for follow up studies (Table S27). The SNP (rs12510722), which shows the 
4
th
 highest MR scores, lies within the alcohol dehydrogenase 6 (ADH6) gene, whose expression is 
affected by pseudohypoxia [47]. The SNPs with the 8
th
 and the 15
th
 highest MR score (rs2660342 and 
rs2660343, respectively) are within 100kb from solute carrier family 30 member 9 (SLC30A9) and 
transmembrane protein 33 (TMEM33). SLC30A9 is up-regulated by hypoxia [27] while TMEM33 is 
down-regulated under hypoxia and up-regulated after knockdown of HIF1A [41].  
Assessing epigenetic differences between high and low altitude populations 
Methylation is an epigenetic modification that is known to play a crucial role in the cellular 
response to hypoxia [48]. Since HA adaptation could be in part maintained by methylation, we measured 
methylation levels at 27,578 CpG sites in 17 HA and 17 LA Amhara and 17 HA and 17 LA Oromo. 
CpG methylation levels were tested in DNA extracted from blood in the Amhara and from saliva in the 
Oromo. To avoid confounding due to differences in methylation across tissues, we performed the 
comparison across altitudes within each ethnic group.  
In Oromo, four CpG sites reached significance after multiple test correction (p <1.85x10
-6
), but 
the closest genes are not known hypoxia candidate genes: apolipoprotein B mRNA editing enzyme 
catalytic polypeptide-like 3G (APOBEC3G), metallothionein 1G (MT1G), paired-like homeodomain 2 
(PITX2) and olfactory receptor family 2 subfamily K member 2 (OR2K2) (Table S28). Interestingly, 
APOBEC3G codes for a well-established cellular antiviral protein and a specific inhibitor of human 
immunodeficiency virus-1 (HIV-1) infectivity [49,50]. The MT1G gene also has a role in HIV-1 
infection because it upregulates MT1G expression in immature dendritic cells, which in turn facilitates 
the expansion of HIV-1 infection [51]. Although the prevalence of HIV was not surveyed in our 
fieldwork, HIV/AIDS is known to be a major health problem in Ethiopia [52,53]. While these functions 
for APOBEC3G and MT1G point to a role for methylation in defense against pathogens, MT1G also 
plays a role in the response to hypoxia as its promoter is induced by vascular endothelial growth factor 
(VEGF), which in turn contributes to the prosurvival and angiogenic functions of VEGF [54]. Likewise, 
expression of PITX2 is required for normal hematopoiesis [55,56], raising the interesting scenario that 
methylation of this gene may influence beneficial phenotypes in the response to hypoxia. Some of the 
CpG sites with nominally significant (p<6.7x10
-5
) differences in methylation between HA and LA are 
close to genes that are differentially expressed in response to hypoxia; these genes include: toll-like 
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receptor 6 (TLR6) [57], mif two 3 homolog 1 (SUMO1) [27]; phosphodiesterase 4A (PDE4A) [58] and 
human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2) [42].  
In Amhara, no CpG site showed a methylation difference that reached significance after multiple 
test correction (Table S29). However, we note that the 3
rd
 most significant differentially methylated CpG 
site (p = 8.03x10
-05
) was closest to Glutathione-S-Transferase (GSTP1) whose expression is increased by 
prolonged hypoxia [59] and whose loss of expression correlates with methylation in prostate cancer 
[60]. Hypoxia also regulates the expression of genes close to other differentially methylated CpG sites in 
Amhara (p<1.5x10
-3
): protein regulator of cytokinesis 1 (PRC1) [42], protein tyrosine phosphatase 
receptor type O (PTPRO) [41], ring finger protein 146 (RNF146) [27] and Ras-related GTP binding D 
(RRAGD) [41].  
Finally, no significant excess of methylation differences between LA and HA populations was 
observed at the genome-wide level in Oromo or Amhara (Figure S19) nor did we find a significant 
enrichment of methylation differences between LA and HA populations for gene sets defined by 
BioCarta or KEGG pathways and by Gene Ontology categories (data not shown).  
 
DISCUSSION 
HA human populations across the world allow studying independent realizations of the adaptive 
process in response to the same selective pressure, i.e. hypoxia, thus providing an excellent opportunity 
to investigate how natural selection shapes the genetic architecture of adaptive traits. To make progress 
on these enduring questions, we have sampled two closely related ethnic groups in the Ethiopian 
highlands that include both HA and LA residents, thus allowing comparisons across altitudes within and 
between ethnic groups. Of these two groups, the Oromo have moved to HA only 500 years ago [61,62], 
thus making it unlikely that genetic adaptations evolved in this group. In contrast, the Amhara have a 
history of HA residence of at least 5ky and possibly as far as 70ky [24,25]. Because previously 
identified selection signals [63,64,65,66] occurred within a similar period of time, including HA 
adaptations [18], we conclude that enough time has elapsed since the Amhara moved to HA for genetic 
adaptations to have taken place. Consistent with this idea, we observe significant phenotypic differences 
between Amhara highlanders and the more recent HA residents, i.e. the Oromo. While HA Amhara are 
characterized by mildly elevated Hb levels (similar to Tibetans) and no or mildly reduced O2 sat [13], 
the HA Oromo sample resembles acclimatized lowlanders with a response characterized by elevated Hb 
concentration and marked reduction in O2 sat. Our data indicates that Amhara and Oromo are very 
similar at the genome-wide level, therefore, the observed phenotypic differences are likely due to the 
different histories of HA occupation. In addition to these phenotypic comparisons, our genomic analyses 
of these two ethnic groups resulted in several important observations that shed new light on the biology 
of HA adaptations and that are discussed in detail below.  
First, in a GWAS of Hb levels in Amhara, we find a genome-wide significant signal of 
association as well as an excess of low p-values. In addition, the second most strongly associated SNP is 
found within the RORA gene, which belongs to HIF1 pathway and is, therefore, an excellent candidate 
gene for hypoxia response phenotypes. Additional strong associations were observed in other candidate 
hypoxia genes, such as COL6A1, SLC30A9, and HGF. We looked at the Amhara data of Scheinfeldt et 
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al [21] to test for replication of the association signal at these genes. Two of them showed suggestive 
associations with Hb levels (p=0.06 and p=0.15 for SLC30A9 and RORA, respectively), with β values (-
0.60 and 1.31, respectively) consistent with ours (-0.67 and 0.92, respectively). It should be noted that 
the replication test was performed in only 21 Amhara samples in Scheinfeldt et al [21] for which age 
and BMI data were available and who had Hb levels within the normal range; thus, the lack of 
replication may well be due to the very low power of the replication sample. We note that, though 
variation in EPAS1 and EGLN1 has been consistently associated with Hb levels in Tibetans, no genome-
wide significant association signal and no excess of low p-values were observed (see Figure S5 in 
Simonson et al [16,17]). While the signals we detected await replication, it is interesting to note that 
their effect sizes are as high as those found in Tibetans for SNPs in EPAS1, thus raising the interesting 
scenario that selection may have favored alleles with similar effect sizes on Hb levels even though the 
specific loci contributing to the trait are different.  
Some interesting patterns are beginning to emerge with regard to the genetic contribution to 
variation in Hb levels and O2 sat, the two phenotypes that have been most widely studied in highlander 
populations. No evidence of a genetic contribution to O2 sat in Amhara, Oromo, and the combined 
Ethiopian sample could be detected (Figures S7-S15). This is true also in the Tibetans, even though 
segregation analysis detected a major O2 sat locus, which is also associated with reproductive success 
[15]. Therefore, the data so far suggest that while genetic factors contribute to variation in Hb levels, 
their importance in O2 sat is lower. This is consistent with studies in Tibetans and Andeans showing a 
markedly lower heritability for O2 sat compared to Hb levels; indeed, the O2 sat heritability in Andeans 
was not significantly different from zero [67,68,69]. More data, especially at the genome-wide level, are 
needed to elucidate the contribution of genetic factors to these two phenotypes. 
Second, to compare the genetic bases of Hb variation with the Tibetans, we tested for an 
association between SNP genotypes and Hb levels within the Ethiopians. Although we had appropriate 
power, none of the SNPs within 10 kb of the EPAS1 and EGLN1 genes or the genes in the hypoxia 
pathway, including SNPs previously associated with Hb variation (and signatures of natural selection) in 
Tibetans, associated with Hb. Therefore, we can rule out that the SNPs and loci contributing to Hb 
variation and showing selection signals in Tibetans affect the same trait in Ethiopians even though 
Tibetans and Amhara have lower Hb levels compared to all other highlanders. Alternatively, if the same 
variant affects Hb levels in both populations, their effect sizes in Amhara must be markedly lower than 
those reported for the Tibetans.  
Third, by using approaches based on allele frequency divergence, we find that outlier SNPs in 
the HA Amhara sample are not in hypoxia response genes, but in loci known to play a role in immune 
defense. These include variation in the HLA-DRA locus and the null allele at the Duffy blood group 
locus; none of these variants is associated with Hb levels or O2 sat. Interestingly, malaria and 
schistosomiasis were prevalent in the LA, but not in the HA Amhara communities sampled in this study 
(Text S1), reflecting important differences in pathogens between HA vs. LA environments. Indeed, 
epidemiological studies in the areas near the LA sampling sites for the Amhara and Oromo reported 
malaria prevalence of 39.6% and as much as 25% of malaria morbidity is due to P. vivax [70,71,72]. 
Therefore, the immune defense variants with extreme frequency divergence represent excellent 
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candidates as selection targets. These findings are important in several respects. First, they indicate that, 
because HA and LA habitats differ by multiple environmental stresses, signals of allele frequency 
divergence cannot be unambiguously attributed to hypoxia without additional information about the 
gene function or the specific phenotypic effects of the alleles. Second, they further corroborate that the 
Amhara populations are indeed adapted to spatially-varying selective pressures, despite likely high 
levels of gene flow between HA and LA communities. Third, the fact that variants in hypoxia response 
genes are not outliers in these analyses suggests that adaptations to pathogens and to hypoxia have a 
different genetic architecture or that the intensity of pathogen-related selective pressures is stronger than 
those due to hypoxia. Overall, these findings highlight the opportunities and challenges of ecological 
genomic studies and point to the power of approaches that use environmental information combined 
with phenotypic data collected in the field.  
Although selection has not created extreme HA vs. LA frequency shifts in hypoxia genes, we 
find the SNPs within candidate genes for response to hypoxia as a group show an excess of allele 
frequency differentiation based on the PBS analysis performed in the Amhara (Table 2). This approach, 
however, requires specification of a set of three populations to be tested. When we used our MR 
approach, which uses information from all populations simultaneously, the response to hypoxia genes 
did not show a significant excess (Table 2). In contrast, both approaches detected a significant excess of 
allele frequency divergence in genes involved in cell cycle control, DNA repair, DNA damage, 
chromatin structure and modification, consistent with the known role of oxygen sensing in the regulation 
of cell proliferation [73]. Therefore, our findings raise the possibility that genetic variation in these 
pathways can contribute to adaptations to HA.  
Fourth, though we did not observe a genome-wide excess of methylation differences between 
HA and LA samples, we found genome-wide significant signals in the Oromo in genes with a known 
function in pathogen defense or in the biology of hypoxia, i.e. VEGF signaling and hematopoiesis. 
Interestingly, no genome-wide significant differential methylation was observed in the Amhara; this 
may be due to the fact that DNA from different tissues was analyzed in the two ethnic groups. However, 
given the difference in the history of HA residence between Amhara and Oromo, it is also possible to 
speculate that epigenetic modifications play a role in the early phases of adaptations to new 
environments and that this role is replaced over time by adaptations at the genetic level.  
It has been proposed that epigenetic modifications are important in ecological adaptations [74] 
and methylation is known to play a crucial role in the cellular response to hypoxia [48]. A previous 
study showed that gene expression differences observed between Moroccan populations were not 
explained by methylation differences on the tested 1,505 CpG sites [75]. Our study is more 
comprehensive having interrogated 27,578 CpG sites in a larger sample size. Though our results do not 
unambiguously point to a major role for methylation in the adaptations to HA, they suggest that further 
studies using DNA extracted from different tissues and including additional epigenetic modifications, in 
addition to methylation, are warranted. 
In conclusion, studies of genetic variation in indigenous populations with long-time residence at 
HA are giving rise to a composite picture regarding the genes contributing to and the genetic 
architecture of HA adaptations. Clearly, different loci contribute to Hb levels in Ethiopians and 
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Tibetans. Moreover, while some aspects (i.e. phenotypic effect sizes) of the genetic architecture of Hb 
levels may be similar, others (i.e. the allele frequency shifts due to selection) are different. Additional 
examples of environmental pressures that acted on different human populations include malarial 
endemia, low UVB radiation levels, and an adult diet rich in dairy products. Detailed genome-wide 
studies of parallel adaptations to these selective pressures are needed to elucidate the impact of natural 
selection on the genetic architecture of complex adaptive traits. 
 
MATERIALS AND METHODS 
Ethics statement 
All participants in the study gave informed consent. The studies were approved by the Institutional 
Review Boards of Case Western Reserve University and of the University of Chicago and by the 
Ethiopian Science and Technology Council Ethics Review Board. 
 
Population samples  
Samples were drawn from native residents of the Semien Mountains area of northern Ethiopia 
inhabited mainly by Christian Amhara and the Bale Mountains area of southern Ethiopia inhabited 
mainly by Muslim Oromo (also referred to as Galla, Boran and Gabbra). For each ethnic group, we 
sampled individuals at HA and LA. The LA samples were chosen to achieve the maximum altitude 
contrast, yet avoid confounding due to the presence of endemic malaria; all LA samples were from 
agropastoral people reporting the same ethnicity as the HA samples and no visits to altitudes above 2500 
m in the past 6 months. For details on the sampled populations and their ecology, see Text S1. 
DNA was extracted from blood samples provided by 192 Amhara individuals living at 3700 m in the 
Simien Mountains National Park or at 1200 m in the town of Zarima. Forty-seven of these individuals 
were sampled in 1995 and previously described [13,76], the remaining 145 individuals were sampled in 
a separate expedition in 2005. DNA was extracted from, saliva samples provided by 118 Oromo 
individuals and collected using Oragene DNA sample collection kits; 79 individuals lived at 4000 m in 
the Bale Mountains National Park while 39 individuals lived at 1560 m in the town of Melkibuta. The 
study participants were healthy (refer to Text S3 for details). Hb and O2 sat of Hb were measured in all 
individuals. Hb was determined in duplicate using the cyanmethemoglobin technique (Hemocue 
Hemoglobinometer, Hemocue AB, Angelholm, Sweden), immediately after drawing a venous blood 
sample. O2 sat was determined by pulse oximetry (Criticare Models 503 and SpO2) as the average of six 
readings taken 10 seconds apart. 
 
SNP Genotyping and imputation 
The samples were genotyped using Hap650Yv3 (n=46), Human1M-duoV3 (n=112), and Human 
Omni-Quad1 (n=160) Illumina arrays at Southern California Genotyping Consortium. Nineteen samples 
with less than 93% genotype call rate were omitted from the analysis. We used the program RELPAIR 
2.0. [77] to test for hidden relatedness in the samples by using 3 independent sets of 1800 autosomal and 
200 X-linked SNPs; individuals with relationships closer than first cousins to any other individual in the 
sample were omitted from the analysis. After applying these filters, 260 unrelated samples remained: 
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102 HA Amhara, 60 LA Amhara, 63 HA Oromo and 35 LA Oromo. Principal component analysis 
(PCA) of the genotype data did not detect any major outlier in either population (see Text S2 and Figure 
S3. Due to the incomplete overlap between SNPs on the three genotyping arrays, genotypes for 
1,819,369 HapMap3 SNPs were imputed by using the program IMPUTE2 [78] and the HapMap 
populations as a reference panel: Utah residents with Northern and Western European ancestry from the 
CEPH collection (CEU), Han Chinese in Beijing, China (CHB), Japanese in Tokyo, Japan (JPT), Luhya 
in Webuye, Kenya (LWK), Maasai in Kinyawa, Kenya (MKK), Toscani in Italy (TSI) and Yoruba in 
Ibadan, Nigeria (YRI) samples. A total of 1,297,134 autosomal SNPs with minor allele frequency 
(MAF) higher than 0 and imputation accuracy higher than 90% were used in the downstream analyses 
(Figure S20). 
 
Genotype-phenotype association 
Phenotype-genotype associations were tested at each SNP with MAF>0.1 by linear regression 
using the whole-genome association analysis toolset in PLINK [79]. To determine whether there was an 
excess of low p-values taking into account the large number of tests performed, the distribution of 
observed p-values from the linear regression tests were compared to a null distribution obtained by 
permuting 100 times the phenotype (and corresponding covariate variables – see below) value across 
individuals and running the same linear model.  The results were visualized by means of quantile-
quantile (QQ) plots and the 95% confidence interval (CI) was estimated by permutations. Gender, body 
mass index (BMI), altitude, ethnic group and year of sampling were used as covariates in the linear 
regression. As an alternative approach, we grouped the samples based on their gender, altitude, ethnic 
group and year of sampling and we quantile normalized the observed phenotypes within each group; 
these phenotypes were then pooled across groups before testing for an association with genotype by 
linear regression. This latter approach preserves information about the individual ranks without 
introducing a bias due to the effects of covariates. However, it does not preserve information about the 
phenotype values, thus leading to a reduction in power. The results of these two approaches correlated 
highly (r
2
> 0.92); therefore, only the results for the linear regression with the covariates are shown. 
 
Population genetics analyses  
The population branch statistic (PBSA_BC) was used to summarize the amount of allele frequency 
change in the history of population A since its divergence from two related populations, B and C [18]. In 
a complementary approach based on multiple regression (MR), we used the allele frequencies for the LA 
Oromo and world-wide population samples (i.e., Human Genome Diversity Project (HGDP) panel 
populations [80] and 4 HapMap Phase III populations -LWK, MKK, TSI and Gujarati Indians in 
Houston, Texas (GIH) - (www.hapmap.org)) to detect SNPs whose HA Amhara frequencies deviate 
most from estimated frequencies. Briefly, denoting the observed allele frequencies in the p populations 
by X1, X2, …, Xp and the expected allele frequency within the HA Amhara by y, we can predict the allele 
frequency for the i
th
 SNP using the linear model yi= β0 + β1Xi1+ β2Xi2 + … +βpXip + εi. Using the data 
from all genotyped SNPs that overlap among the p populations and applying multivariate linear 
regression, we found b0, b1, b2, …, bp , which are estimates of parameters β0, β1, β2, …, βp and estimated 
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the magnitude of the residual for the i
th
 SNP as |εi|= |yi - (b0 + b1X1 + b2X2 + … + bpXp)|. We refer to this 
residual as the MR score.  
To test for an enrichment of allele frequency differentiation in candidate hypoxia genes, we 
focused on the 28 genes belonging to the “Response to hypoxia” category in the Gene Ontology 
database (GO:0001666). We then compared the proportion of SNPs within 10 kb of each gene in this 
category to that of SNPs within 10 kb of all other genes in the tail of the PBS and MR score 
distributions. Given the arbitrary nature of choosing a single cutoff for the tail of the distribution, we set 
three cutoffs (5%, 1% and 0.5%). In other words, we looked at the top 5%, 1% and 0.5% of all PBS and 
MR values and asked whether there is an enrichment of hypoxia gene SNPs relative to all other genic 
SNPs for each tail cut-off. A value of 1 represents no excess and a value greater than 1 represents 
enrichment in the tail of the distribution. SNPs are likely to cluster along the genome due to linkage 
disequilibrium, thus reducing the number of independent signals contributing to an observed enrichment. 
To account for this possibility, we found the confidence interval for the enrichment using a bootstrap 
approach described in Hancock et al [81]. An enrichment of hypoxia SNPs was considered significant 
(with a one-tailed test) if at least 95% of the 1000 bootstrap replicates were enriched (i.e., had a ratio 
above 1). 
 
Methylation  
Methylation levels were measured at 27,578 CpG sites in 17 HA and 17 LA Amhara and Oromo 
DNA samples, for a total of 68 individuals, using six Infinium HumanMethylation27 arrays at Southern 
California Genotyping Consortium. Two LA Amhara sample data were discarded due to low data 
quality. In each ethnic group, the HA methylation level of each CpG site was compared to 
corresponding LA levels using the following linear model correcting for age, gender, and the 
methylation array: lm (% methylation ~ altitude + gender + age + [array]). Two comparisons were 
performed: (1) HA vs. LA Amhara and (2) HA vs. LA Oromo. As for the genotype-phenotype 
association, excess of differential methylation between HA and LA was tested by comparing the 
observed p-value distribution to the null distribution obtained by permuting 100 times the altitude label 
across individuals and running the same linear model. Permutation based 95% CI was estimated. 
 
ACKNOWLEDGMENTS  
The authors are grateful to the study participants and communities for their hospitality and 
cooperation in their field work. They thank the officials of the Ethiopian Science and Technology 
Commission, the Amhara and the Oromia Regional Governments, and the staffs of the Semien 
Mountains and Bale Mountains National Parks for permissions and local arrangements. The Frankfurt 
Zoological Society generously allowed use of the Wolf Research Camp in the Bale Mountains. Daniel 
Tessema, laboratory technician, and Gezahegne Fentahun, M.D. of Addis Ababa University worked in 
both field sites. The authors also thank members of the Di Rienzo lab, John Marioni, Jordana T. Bell and 
Lucy Godley for helpful discussions during the course of this project as well as Sarah Tishkoff and 
Laura Scheinfeldt for sharing data on genotype-phenotype association in their samples.  
REFERENCES 
15 
 
 
1. Rytkonen KT, Storz JF (2011) Evolutionary origins of oxygen sensing in animals. EMBO Rep 12: 3-4. 
2. Moore LG, Shriver M, Bemis L, Hickler B, Wilson M, et al. (2004) Maternal adaptation to high-altitude 
pregnancy: an experiment of nature--a review. Placenta 25 Suppl A: S60-71. 
3. Brutsaert TD (2008) Do high-altitude natives have enhanced exercise performance at altitude? Appl Physiol 
Nutr Metab 33: 582-592. 
4. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG (1997) Blood viscosity and risk of cardiovascular events: the 
Edinburgh Artery Study. Br J Haematol 96: 168-173. 
5. Danesh J, Collins R, Peto R, Lowe GD (2000) Haematocrit, viscosity, erythrocyte sedimentation rate: meta-
analyses of prospective studies of coronary heart disease. Eur Heart J 21: 515-520. 
6. Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, et al. (2005) Prognostic impact of low-shear whole 
blood viscosity in hypertensive men. Eur J Clin Invest 35: 93-98. 
7. Gonzales GF, Steenland K, Tapia V (2009) Maternal hemoglobin level and fetal outcome at low and high 
altitudes. Am J Physiol Regul Integr Comp Physiol 297: R1477-1485. 
8. Aldenderfer M (2011) Peopling the Tibetan plateau: insights from archaeology. High Alt Med Biol 12: 141-147. 
9. Aldenderfer MS (2003) Moving Up in the World; Archaeologists seek to understand how and when people 
came to occupy the Andean and Tibetan plateaus. Am Sci: 542-549. 
10. Pleurdeau D (2006) Human Technical Behavior in the African Middle Stone Age:  The Lithic Assemblange of 
Porc-Epic Cave (Dire Dawa, Ethiopia). Afr Archaeol Rev 177-197. 
11. Beall CM (2006) Andean, Tibetan, and Ethiopian patterns of adaptation to high-altitude hypoxia. Integr Comp 
Biol 46: 18-24. 
12. Beall CM (2007) Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl 
Acad Sci U S A 104 Suppl 1: 8655-8660. 
13. Beall CM, Decker MJ, Brittenham GM, Kushner I, Gebremedhin A, et al. (2002) An Ethiopian pattern of 
human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A 99: 17215-17218. 
14. Hoit BD, Dalton ND, Gebremedhin A, Janocha A, Zimmerman PA, et al. (2011) Elevated pulmonary artery 
pressure among Amhara highlanders in Ethiopia. Am J Hum Biol 23: 168-176. 
15. Beall CM, Song K, Elston RC, Goldstein MC (2004) Higher offspring survival among Tibetan women with high 
oxygen saturation genotypes residing at 4,000 m. Proc Natl Acad Sci U S A 101: 14300-14304. 
16. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, et al. (2010) Genetic evidence for high-altitude adaptation in 
Tibet. Science 329: 72-75. 
17. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, et al. (2010) Natural selection on EPAS1 (HIF2alpha) 
associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 107: 
11459-11464. 
18. Yi X, Liang Y, Huerta-Sanchez E, Jin X, Cuo ZX, et al. (2010) Sequencing of 50 human exomes reveals 
adaptation to high altitude. Science 329: 75-78. 
19. Storz JF, Scott GR, Cheviron ZA (2010) Phenotypic plasticity and genetic adaptation to high-altitude hypoxia 
in vertebrates. J Exp Biol 213: 4125-4136. 
20. Bigham A, Bauchet M, Pinto D, Mao X, Akey JM, et al. (2010) Identifying signatures of natural selection in 
Tibetan and Andean populations using dense genome scan data. PLoS Genet 6. 
21. Scheinfeldt LB, Soi S, Thompson S, Ranciaro A, Meskel DW, et al. (2012) Genetic adaptation to high altitude 
in the Ethiopian highlands. Genome Biol 13: R1. 
22. Hassen M (1990) The Oromo of Ethiopia: a history, 1570-1860. Great Britain: Cambridge University Press. 
23. Lewis HS (1966) The Origins of the Galla and Somali. The Journal of African History 7: 27-46. 
24. Aldenderfer MS (2003) Moving Up in the World; Archaeologists seek to understand how and when people 
came to occupy the Andean and Tibetan plateaus. American Scientist 91: 542-549. 
25. Pleurdeau D (2006) Human Technical Behavior in the African Middle Stone Age:  The Lithic Assemblange of 
Porc-Epic Cave (Dire Dawa, Ethiopia). African Archaeological Review 22: 177-197. 
16 
 
26. Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, et al. (2008) Transcriptional activation of HIF-1 by RORalpha and its 
role in hypoxia signaling. Arterioscler Thromb Vasc Biol 28: 1796-1802. 
27. Jiang Y, Zhang W, Kondo K, Klco JM, St Martin TB, et al. (2003) Gene expression profiling in a renal cell 
carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res 1: 453-462. 
28. O'Connell K, Posthumus M, Collins M (2011) COL6A1 gene and Ironman triathlon performance. Int J Sports 
Med 32: 896-901. 
29. Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, et al. (2012) The von Hippel-Lindau tumor suppressor protein 
regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 31: 776-
786. 
30. Kitajima Y, Ide T, Ohtsuka T, Miyazaki K (2008) Induction of hepatocyte growth factor activator gene 
expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible 
factor-1 in pancreatic cancer. Cancer Sci 99: 1341-1347. 
31. Tacchini L, Dansi P, Matteucci E, Desiderio MA (2001) Hepatocyte growth factor signalling stimulates hypoxia 
inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22: 1363-1371. 
32. He F, Wu LX, Shu KX, Liu FY, Yang LJ, et al. (2008) HGF protects cultured cortical neurons against 
hypoxia/reoxygenation induced cell injury via ERK1/2 and PI-3K/Akt pathways. Colloids Surf B 
Biointerfaces 61: 290-297. 
33. Kimura K, Teranishi S, Kawamoto K, Nishida T (2010) Protection of human corneal epithelial cells from 
hypoxia-induced disruption of barrier function by hepatocyte growth factor. Exp Eye Res 90: 337-343. 
34. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. 
PLoS Biol 4: e72. 
35. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, et al. (2007) Genome-wide detection and 
characterization of positive selection in human populations. Nature 449: 913-918. 
36. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, et al. (2009) Signals of recent positive selection in a 
worldwide sample of human populations. Genome Res 19: 826-837. 
37. Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene 
promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10: 224-228. 
38. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, et al. (2009) Reduced neutrophil count in people of 
African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS 
Genet 5: e1000360. 
39. Yuan WC, Lee YR, Huang SF, Lin YM, Chen TY, et al. (2011) A Cullin3-KLHL20 Ubiquitin ligase-dependent 
pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell 20: 214-
228. 
40. Lombardi MS, van den Tweel E, Kavelaars A, Groenendaal F, van Bel F, et al. (2004) Hypoxia/ischemia 
modulates G protein-coupled receptor kinase 2 and beta-arrestin-1 levels in the neonatal rat brain. 
Stroke 35: 981-986. 
41. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, et al. (2006) Concordant regulation of gene 
expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-
2alpha, and other pathways. J Biol Chem 281: 15215-15226. 
42. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, et al. (2005) Transcriptional regulation of vascular 
endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669. 
43. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, et al. (2002) Cytoskeletal changes in hypoxic 
pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277: 
42596-42602. 
44. Chakkalakal JV, Stocksley MA, Harrison MA, Angus LM, Deschenes-Furry J, et al. (2003) Expression of 
utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated 
by calcineurin/NFAT signaling. Proc Natl Acad Sci U S A 100: 7791-7796. 
17 
 
45. Stepto NK, Coffey VG, Carey AL, Ponnampalam AP, Canny BJ, et al. (2009) Global gene expression in skeletal 
muscle from well-trained strength and endurance athletes. Med Sci Sports Exerc 41: 546-565. 
46. Gramolini AO, Belanger G, Thompson JM, Chakkalakal JV, Jasmin BJ (2001) Increased expression of utrophin 
in a slow vs. a fast muscle involves posttranscriptional events. Am J Physiol Cell Physiol 281: C1300-1309. 
47. Cervera AM, Apostolova N, Crespo FL, Mata M, McCreath KJ (2008) Cells silenced for SDHB expression 
display characteristic features of the tumor phenotype. Cancer Res 68: 4058-4067. 
48. Watson JA, Watson CJ, McCann A, Baugh J (2010) Epigenetics, the epicenter of the hypoxic response. 
Epigenetics 5: 293-296. 
49. Norman JM, Mashiba M, McNamara LA, Onafuwa-Nuga A, Chiari-Fort E, et al. (2011) The antiviral factor 
APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 
12: 975-983. 
50. Wang X, Ao Z, Chen L, Kobinger G, Peng J, et al. (2012) The cellular antiviral protein APOBEC3G interacts with 
HIV-1 reverse transcriptase and inhibits its function during viral replication. J Virol 86: 3777-3786. 
51. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, et al. (2003) HIV-1 Tat reprograms immature dendritic 
cells to express chemoattractants for activated T cells and macrophages. Nat Med 9: 191-197. 
52. Kebede D, Aklilu M, Sanders E (2000) The HIV epidemic and the state of its surveillance in Ethiopia. Ethiop 
Med J 38: 283-302. 
53. Hladik W, Shabbir I, Jelaludin A, Woldu A, Tsehaynesh M, et al. (2006) HIV/AIDS in Ethiopia: where is the 
epidemic heading? Sex Transm Infect 82 Suppl 1: i32-35. 
54. Joshi B, Ordonez-Ercan D, Dasgupta P, Chellappan S (2005) Induction of human metallothionein 1G promoter 
by VEGF and heavy metals: differential involvement of E2F and metal transcription factors. Oncogene 
24: 2204-2217. 
55. Kieusseian A, Chagraoui J, Kerdudo C, Mangeot PE, Gage PJ, et al. (2006) Expression of Pitx2 in stromal cells 
is required for normal hematopoiesis. Blood 107: 492-500. 
56. Zhang HZ, Degar BA, Rogoulina S, Resor C, Booth CJ, et al. (2006) Hematopoiesis following disruption of the 
Pitx2 homeodomain gene. Exp Hematol 34: 167-178. 
57. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK (2007) Hypoxia inducible factor (HIF)-1 
coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2: e1364. 
58. Millen J, MacLean MR, Houslay MD (2006) Hypoxia-induced remodelling of PDE4 isoform expression and 
cAMP handling in human pulmonary artery smooth muscle cells. Eur J Cell Biol 85: 679-691. 
59. Liu YL, Song XR, Wang XW, Wei L, Li DP (2007) [Prolonged hypoxia induces GST-pi expression and drug 
resistance in lung adenocarcinoma cell line SPCA1]. Zhonghua Jie He He Hu Xi Za Zhi 30: 108-111. 
60. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, et al. (1999) Detailed methylation analysis of the glutathione 
S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 18: 1313-1324. 
61. Hassen M (1990) The Oromo of Ethiopia: a history, 1570-1860. : Great Britain: Cambridge University Press. 
62. Lewis H (1966) The Origins of the Galla and Somali. The Journal of African History 7: 27-46. 
63. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, et al. (2001) Haplotype diversity and linkage 
disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293: 455-
462. 
64. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, et al. (2007) Convergent adaptation of human 
lactase persistence in Africa and Europe. Nat Genet 39: 31-40. 
65. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, et al. (2004) Genetic signatures of strong 
recent positive selection at the lactase gene. Am J Hum Genet 74: 1111-1120. 
66. Enattah NS, Jensen TG, Nielsen M, Lewinski R, Kuokkanen M, et al. (2008) Independent introduction of two 
lactase-persistence alleles into human populations reflects different history of adaptation to milk 
culture. Am J Hum Genet 82: 57-72. 
67. Beall CM, Strohl KP, Blangero J, Williams-Blangero S, Decker MJ, et al. (1997) Quantitative genetic analysis of 
arterial oxygen saturation in Tibetan highlanders. Hum Biol 69: 597-604. 
18 
 
68. Beall CM, Brittenham GM, Strohl KP, Blangero J, Williams-Blangero S, et al. (1998) Hemoglobin concentration 
of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 106: 385-400. 
69. Beall CM, Almasy LA, Blangero J, Williams-Blangero S, Brittenham GM, et al. (1999) Percent of oxygen 
saturation of arterial hemoglobin among Bolivian Aymara at 3,900-4,000 m. Am J Phys Anthropol 108: 
41-51. 
70. Alemu A, Muluye D, Mihret M, Adugna M, Gebeyaw M (2012) Ten year trend analysis of malaria prevalence 
in Kola Diba, North Gondar, Northwest Ethiopia. Parasit Vectors 5: 173. 
71. Endeshaw T, Graves PM, Ayele B, Mosher AW, Gebre T, et al. (2012) Performance of local light microscopy 
and the ParaScreen Pan/Pf rapid diagnostic test to detect malaria in health centers in Northwest 
Ethiopia. PLoS One 7: e33014. 
72. Woyessa A, Deressa W, Ali A, Lindtjorn B (2012) Prevalence of malaria infection in Butajira area, south-
central Ethiopia. Malar J 11: 84. 
73. Semenza GL (2011) Hypoxia. Cross talk between oxygen sensing and the cell cycle machinery. Am J Physiol 
Cell Physiol 301: C550-552. 
74. Bossdorf O, Richards CL, Pigliucci M (2008) Epigenetics for ecologists. Ecol Lett 11: 106-115. 
75. Idaghdour Y, Storey JD, Jadallah SJ, Gibson G (2008) A genome-wide gene expression signature of 
environmental geography in leukocytes of Moroccan Amazighs. PLoS Genet 4: e1000052. 
76. Beall CM, Gebremedhin A, Brittenham GM, Decker MJ, Shamebo M (1997) Blood pressure variation among 
Ethiopians on the Simien Plateau. Ann Hum Biol 24: 333-342. 
77. Epstein MP, Duren WL, Boehnke M (2000) Improved inference of relationship for pairs of individuals. Am J 
Hum Genet 67: 1219-1231. 
78. Howie BN, Donnelly P, Marchini J (2009) A flexible and accurate genotype imputation method for the next 
generation of genome-wide association studies. PLoS Genet 5: e1000529. 
79. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome 
association and population-based linkage analyses. Am J Hum Genet 81: 559-575. 
80. Li JZ, Absher DM, Tang H, Southwick AM, Casto AM, et al. (2008) Worldwide human relationships inferred 
from genome-wide patterns of variation. Science 319: 1100-1104. 
81. Hancock AM, Witonsky DB, Alkorta-Aranburu G, Beall CM, Gebremedhin A, et al. (2011) Adaptations to 
climate-mediated selective pressures in humans. PLoS Genet 7: e1001375. 
82. Lewis MP, editor (2009) Ethnologue: Languages of the World, Sixteenth edition. Dallas, Tex.: SIL 
International. 
83. Beall CM, Gebremedhin A, Brittenham GM, Shamebo M (1997) Blood pressure variation among Ethiopians at 
3530m on the Simien Plateau. Annals of Human Biology 24: 333-342. 
84. Hancock AM, Witonsky DB, Ehler E, Alkorta-Aranburu G, Beall C, et al. (2010) Colloquium paper: human 
adaptations to diet, subsistence, and ecoregion are due to subtle shifts in allele frequency. Proc Natl 
Acad Sci U S A 107 Suppl 2: 8924-8930. 
85. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype 
data. Genetics 155: 945-959. 
86. West JB (1985) Respiratory Physiology - The Essentials. Baltimore, MD.: Williams &Wilkins  
87. Hoit BD, Dalton ND, Gebremedhin A, Janocha A, Zimmerman PA, et al. (2011) Elevated pulmonary artery 
pressure among Amhara highlanders in Ethiopia. American journal of human biology 23: 168-176. 
88. Cook JD, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101: 3359-3364. 
89. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edition. Hillsdale, NJ: Lawrence 
Earlbaum Associates. 
 
  
19 
 
Table 1. Association test of Tibetan EGLN1 and EPAS1 SNPs within Amhara, Oromo and combined Ethiopians. 
 
  
Tibetans
1 
Amhara Oromo Ethiopians 
SNP Gene 2 MAF
 
2 p Power
3
 MAF 2 p Power
3
 MAF 2 p Power
3
 
rs961154 EGLN1 1.70 0.39 0.08 0.58 100 0.41 0.13 0.57 100 0.40 0.12 0.34 100 
rs2790859 EGLN1 1.70 0.39 0.08 0.58 100 0.41 0.13 0.57 100 0.40 0.12 0.34 100 
rs1992846 EPAS1 0.84 0.36 0.00 0.99 100 0.42 -0.39 0.13 100 0.38 -0.14 0.29 100 
rs7594278 EPAS1 0.52 0.31 0.06 0.71 98 0.24 -0.08 0.77 80 0.28 -0.01 0.93 100 
rs6544887 EPAS1 0.79 0.34 -0.05 0.74 100 0.34 -0.11 0.63 100 0.34 -0.07 0.58 100 
rs17035010 EPAS1 0.84 0.39 -0.07 0.66 100 0.30 -0.02 0.93 100 0.36 -0.04 0.80 100 
rs3768729 EPAS1 0.80 0.44 0.10 0.52 100 0.44 -0.08 0.74 100 0.44 0.04 0.77 100 
rs7583554 EPAS1 0.94 0.46 0.10 0.52 100 0.41 0.16 0.53 100 0.44 0.13 0.34 100 
rs7583088 EPAS1 0.92 0.30 0.10 0.51 100 0.22 -0.07 0.79 100 0.27 0.02 0.87 100 
rs11678465 EPAS1 0.85 0.30 0.10 0.51 100 0.22 -0.06 0.83 100 0.27 0.03 0.84 100 
rs6712143 EPAS1 0.94 0.40 0.16 0.28 100 0.32 -0.09 0.74 100 0.37 0.09 0.52 100 
rs4953342 EPAS1 0.90 0.21 -0.12 0.50 100 0.12 -0.19 0.57 99 0.18 -0.16 0.33 100 
rs2121266 EPAS1 1.02 0.38 0.14 0.34 100 0.30 -0.20 0.43 100 0.35 0.01 0.95 100 
rs9973653 EPAS1 0.52 0.35 0.01 0.95 100 0.30 -0.18 0.47 100 0.33 -0.05 0.70 100 
rs1374749 EPAS1 0.88 0.47 -0.18 0.18 100 0.49 -0.29 0.20 100 0.48 -0.22 0.07 100 
rs4953353 EPAS1 0.97 0.31 -0.01 0.93 100 0.31 -0.19 0.46 100 0.31 -0.08 0.54 100 
rs6756667 EPAS1 0.93 0.37 0.02 0.89 100 0.32 0.04 0.86 100 0.35 0.03 0.82 100 
rs7571218 EPAS1 0.71 0.50 0.17 0.22 100 0.49 -0.19 0.46 100 0.50 0.06 0.64 100 
 
1
 Genotype-phenotype association  coefficients for EGLN1 were obtained from Simonson et al [16] while those for EPAS1 were 
obtained from Beall et al [17]. 
2
  indicates the observed linear coefficient for the relationship between SNP genotype and Hb levels. 
3
 Power refers to the probability of detecting a significant association (p<0.05) between SNP genotype and Hb level given the MAF 
and the sample size in the Ethiopian populations assuming that the  coefficient is as high or higher as that observed in Tibetans.
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Table 2. Biological pathways for which a significant excess of genic relative to all other genic SNPs are observed for all three tail cut-
offs of the Amhara PBS, Amhara High PBS, or Amhara High MR distributions, respectively. * and ** denote support from ≥ 95% and 
99% of bootstrap replicates, respectively. 
 
  
Amhara PBS  Amhara High PBS  Amhara High MR 
  
tail cut-off tail cut-off tail cut-off 
Classification Gene Set 0.01 0.01 0.05 0.01 0.01 0.05 0.01 0.01 0.05 
GO BP RESPONSE TO HYPOXIA 3.40* 3.41** 1.84* 3.31 2.9 1.92* 2.58 2.2 1.75** 
GO BP CELL CYCLE CHECKPOINT 5.72** 3.40** 1.83** 0.48 0.96 0.96 0.68 0.36 0.9 
GO BP DNA INTEGRITY CHECKPOINT 6.30** 3.86** 2.00* 0 0.82 0.94 0 0.07 0.85 
GO BP 
DNA DAMAGE RESPONSE AND 
SIGNAL TRANSDUCTION 
4.83** 2.91** 1.59* 2.02 1.79 1.07 1.12 1.26 1.18 
GO BP DNA DAMAGE CHECKPOINT 6.47** 4.00** 1.97** 0 0.9 0.94 0 0.09 0.81 
GO BP 
SENSORY ORGAN 
DEVELOPMENT 
10.29* 6.08* 2.31* 2.72 1.36 0.87 1.9 0.95 1.04 
BioCarta SALMONELLA PATHWAY 15.61* 9.63** 2.89* 0 0 0.91 0 0 0.31 
KEGG CELL CYCLE 1.1 1.1 1.39* 2.93** 2.70** 1.60** 4.39* 3.35* 1.34 
KEGG CHRONIC MYELOID LEUKEMIA 1.23 1.24 1.34 2.72* 2.02** 1.44* 2.67* 2.09* 1.1 
GO BP CELLULAR RESPIRATION 0 1.01 0.69 4.55* 3.07* 2.20** 1.11 2.25 2.42* 
GO BP AXON GUIDANCE 0.35 0.62 0.8 1.97* 1.72** 1.28* 0.47 0.95 0.93 
GO BP 
CHROMOSOME ORGANIZATION 
AND BIOGENESIS 
0.69 0.77 0.87 1.46 2.22* 1.46* 3.93** 3.17** 1.99** 
GO BP DNA REPAIR 1.76 1.2 1.22 1.83 1.6 1.36* 2.23* 2.41** 1.64** 
GO BP 
ESTABLISHMENT AND OR 
MAINTENANCE OF CHROMATIN 
ARCHITECTURE 
0.73 0.91 0.83 1.78 2.09 1.39* 3.31* 2.57* 1.74** 
GO BP HISTONE MODIFICATION 1.76 1.76 0.95 1.58 2.28 1.26 5.58* 4.57* 2.34** 
GO BP CHROMATIN MODIFICATION 0.96 0.97 0.84 2.4 2.4 1.37 4.29* 3.34* 1.75* 
GO BP ALCOHOL METABOLIC PROCESS 1.44 1.18 0.93 2.1 1.84 1.15 3.48** 2.51* 1.53* 
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Figure 1. Hemoglobin and oxygen saturation measurements. Box plots describe variation in the Amhara 05 (dark grey boxes), 
Amhara 95 (grey boxes) and Oromo (white boxes) for Hb concentration (g/dL) among males (A) and females (B) and for O2 sat also 
among males (E) and females (F). Box plots show the median (horizontal line), interquartile range (box), and range (whiskers), except 
the extreme values represented by circles. Statistically significant differences after multiple test correction between groups (unpaired 
two-sided two-sample t-test) are bolded in C, D, G, and H. 
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Figure 2. Hemoglobin association test within Amhara. The QQplot represents the excess of strong association with Hb among 
Amhara individuals (A). The observed –log10 p-value distribution is ranked from smallest to largest and plotted (y-axis) against the 
expected –log10 p-value (y-axis) in black. The grey area indicates the 95% confidence interval (see methods). Genome-wide (GW) 
significance level (after multiple test correction) is indicated by the dashed line. The Manhattan plot (B) shows the GW significance 
achieved by a set of high-LD SNPs in chromosome 1. The box plots describe the correlation between hemoglobin levels and the 3 
genotypes of the top and GW significant SNP (rs10803083) among high (C) and low altitude (D) Amhara. 
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Figure 3. Power plots. The effect of β and MAF on the power of association tests based on the Ethiopian sample size (corrected for 
the number of SNPs tested within 10kb from gene) is illustrated for EPAS1 (A, 72 SNPs)), EGLN1 (B, 38 SNPs) and any gene within 
the Response to Hypoxia gene ontology category (C, 1309 SNPs). 
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SUPPORTING TEXT 
 
Text S1. Sampled populations and their ecology 
 
The Simien Plateau in Northwest Ethiopia is cut by streams and rivers and has cliffs and land areas 
sloping down to canyons. The high altitude (HA) Amhara are agropastoralists living in a temperate 
Afro-alpine ecosystem in the Simien Mountains National Park at altitudes ranging from 3500-4100 
meters (m). Altitudes above 2500m on the East African Plateau have been inhabited for at least 5 
thousand years (ky) and altitudes around 2300-2400m for more than 70ky [24,25]. Linking historical 
and modern ethnic groups in Ethiopia with prehistoric sites is not feasible with current knowledge. This 
paper considers that 5ky is a reasonable lower estimate for human habitation of this area. The Bale 
Plateau in Southeast Ethiopia is a flat mesa with sharp relief down to the lowlands. The HA Oromo are 
pastoralists herding cattle, sheep and goats and living in a temperate Afro-alpine ecosystem in the Bale 
Mountains National park and reside on the Sanetti Plateau at 4000-4100m. The HA areas of the Bale 
Plateau have been inhabited by Oromo since the early 1500s according to historical records [22,23]. The 
two plateaus are about 500 miles apart and the intervening terrain is not a continuous plateau as the 
Tibetan or Andean, instead it is a mosaic of terrain generally above 1500m and punctuated by lowlands 
including the Great Rift Valley. The Amhara language is sub-classified as Ethio-Semitic and Oromo as 
Eastern Cushitic in the Afroasiatic language group [82] (http://www.ethnologue.com/ - accessed 
February 27, 2012). 
Data were collected in field laboratories in the four communities. The Amhara samples provided 
data during December 1995, April 2005, December 2005 and January 2006. In 2005-6, they were 
studied at a field laboratory established in a park guard camp at 3700m. In 1995, they were studied at an 
altitude of 3530m [13,83]. Ambient conditions at the time of morning calibrations in 2005 and 2006 
averaged 498 mmHg, 6 °C and 36% relative humidity at the HA site, 659 mmHg, 22 °C, and 36% 
relative humidity at the LA site. The Oromo samples provided data during December 2005 and January 
2006 when ambient conditions averaged 469mm Hg and 3°C at the HA site and 635 mmHg, 15°C at the 
LA site. They were studied at a field laboratory established at the Wolf Research Camp at 4000m and in 
Melkibuta town at 1500m. 
The Amhara reported occupations as farmers and, at LA, farmers and traders. The HA sample 
reported eating a diet based on barley injera (a flat crepe-like bread made of fermented dough) with 
sauce (wot) of potato or beans. The LA Amhara community was exposed to malaria and schistosomiasis 
and had a high prevalence of visible goiter and iron deficiency. Such individuals were excluded from the 
sample. The HA Oromo sample reported eating a diet of teff injera with potato or bean wot and some 
meat and dairy products. The LA Oromo were farmers, traders, and government officials such as 
teachers; they were also exposed to malaria.   
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Text S2. The genetic structure of the Amhara and Oromo populations 
 
In order to investigate the genetic relationship between Amhara and Oromo and other populations, 
we used genotype data in the two Ethiopian populations for SNPs that had previously been typed also in 
a set of 60 worldwide populations, namely 52 Human Genome Diversity Project (HGDP) populations, 4 
HapMap populations (Gujarati Indians in Houston, Texas (GIH); Maasai in Kinyawa, Kenya (MKK); 
Luhya in Webuye, Kenya (LWK); Toscani in Italia (TSI)), and 4 populations from Hancock et al [84]. A 
neighbor-joining tree shows the relationships of the Ethiopian populations to the worldwide populations 
(Figure S1). As expected, Oromo and Amhara cluster closely together in the tree and occupy an 
intermediate position between African (with the exception of the Mozabites) and non-African 
populations. This position is further supported by the Bayesian clustering analysis performed using the 
program STRUCTURE [85]. In this analysis, 3 different sets of 57652 SNPs were used to infer the 
ancestral composition of each population assuming 7 ancestral groups. The STRUCTURE plots clearly 
show that Ethiopian populations share ancestral components with sub-Saharan African and Middle 
Eastern populations falling in the middle of the ancestry gradient between these two groups of 
populations (Figure S2. We also calculated the haplotype diversity and compared it to that observed in 
the worldwide populations. Interestingly, the Oromo (0.822) and Amhara (0.810) haplotype diversity 
values are as high as or higher than the highest values [80] observed in the HGDP, i.e. Bantu (0.818), 
Biaka Pygmies (0.815), Yoruba (0.815) and Mandenka (0.807); this is true regardless of altitude (0.798 
for HA Amhara; 0.803 for LA Amhara, 0.813 for HA Oromo, and 0.813 for LA Oromo).  
To look more closely at the relationship between the Amhara and the Oromo, we performed 
principal component analysis (PCA) using the genotype data from 13,000 random autosomal SNPs for 
all Ethiopian individuals. In this analysis, PC1, which explains 0.78% of the variance, separates the 
majority of the Amhara from the majority of the Oromo individuals; in addition, within each ethnic 
group, the HA and LA individuals tend to cluster separately (Figure S3. Accordingly, the mean FST
 
between LA Amhara and Oromo is very low (0.0098), though it is higher than the mean FST between LA 
and HA populations within the same ethnic group (HA vs. LA Amhara: FST=0.0047; HA vs. LA Oromo 
high FST=0.0074). The STRUCTURE analysis did not reveal detectable differences between the HA and 
LA populations (10
6
 iterations; following a burn-in period of 30,000 iterations; k=3) (Figure S4. 
However, when we compared the FST distribution between HA and LA populations (Amhara or Oromo) 
to the distribution obtained by permuting the altitude labels (i.e. under random mating for HA and LA 
populations within each ethnic group) we detected a significant excess of high FST values, indicating that 
some population structure between altitudes does exist (Figure S5). In order to test for an excess of allele 
frequency divergence between populations, the observed distribution of FST was compared to a null 
distribution obtained by permuting the population labels 100 times, and for each comparison, a different 
permuted FST distribution was created. Permutations were used to estimate the 95% confidence interval.  
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Text S3. Phenotypic variation in Amhara and Oromo 
 
260 unrelated people provided the phenotype and genotype data presented here. HA Amhara 
were sampled in 1995 (n=47) and 2005 (n=65) and the LA Amhara in 2005-6 (n=59). All Oromo were 
sampled in 2007 (n=88). These unrelated people were identified from a larger sample of partially related 
individuals.  
In the Semien Mountain area, two models of Criticare oximeter were used, the Criticare Model 
503 was used for 152 people and the SpO2 was used for 150 people. Twenty-five people were measured 
using both instruments and the average difference (SpO2 minus 503) was =0.031 + 2 (SD) %. One 
observation was just outside the limits of agreement of the two models (+ 2 SDs). The Model 503 values 
were used as the O2 sat measured by Criticare oximeter for the 127 who did not have SpO2 
measurements. 
Table S1 summarizes height, weight, body mass index (BMI), and pulse. Considering altitude 
differences, HA Amhara native men and women were shorter, lighter and had lower BMI than their 
lowland Amhara counterparts. HA Oromo native men had higher BMI than their lowland Oromo 
counterparts although there were no significant differences in height or weight. HA Oromo native 
women were shorter but did not differ in weight or BMI from their lowland counterparts. Considering 
ethnic differences within altitude zones, HA Amhara men and women were shorter, lighter and had 
lower BMI than Oromo. LA Amhara men were heavier and had higher BMIs. Amhara lowland women 
did not differ from Oromo lowland women in these characteristics although there was a trend toward 
shorter height.  
Table S2 summarizes the three HA adaptation phenotypes, hemoglobin (Hb) concentration, 
percent of oxygen saturation (O2 sat) of Hb and calculated arterial oxygen content (AOC). Arterial 
oxygen content in ml O2/dL was calculated as 1.39*(Hb*O2 sat)/100 [86]. Phenotypes were assessed 
using the same equipment and protocols in all areas [13]. To remove many possible confounding factors 
that could have added spurious variation to the phenotypes, the analyses were confined to healthy people 
(based on self-report and a review of systems by an Ethiopian physician), who were free of respiratory 
symptoms, not hypertensive, not pregnant, had not delivered an infant in the past year and had not 
visited at another altitude (below 2500m for highlanders or above 2500m for lowlanders) in the past six 
months. Samples collected in 2005, 2006 and 2007 were also screened for normal lung function and for 
infection with all four species of human-associated malaria [87]. Furthermore, because poor iron status 
could limit the Hb response to HA hypoxia, the analyses were limited to those with normal iron status. 
Iron deficiency in the 1995 sample was identified on the bases of zinc erythrocyte protoporphyrin > 70 
gm/dL, plasma ferritin concentration <12 ng/ml or transferrin receptor concentration <8.3 g/L [13]. Iron 
deficiency in the samples collected later was identified on the bases of body iron stores calculated using 
the log of the ratio of transferrin receptor to ferritin concentration [88]. If an individual were missing 
data for any of these variables, then his or her Hb concentration data were not analyzed for association 
with genetic variants. Stringent criteria for phenotypes improve the likelihood of finding phenotypic 
variation associated with health, normal genetic variation and add confidence to findings of a lack of 
association.  
27 
 
With respect to altitude differences, Hb was significantly higher among all four HA samples 
compared with the age-sex groups at LA but size of the effect was smaller among the Amhara (Table S2 
and Figure S6. Similarly, the percent of O2 sat was lower among all four HA samples compared with the 
age-sex groups at LA, but the size of the effect was smaller among the Amhara (Table S2 and Figure S6. 
The altitude sub-samples did not differ from one another in calculated AOC. With respect to ethnic 
group differences within altitude zones, Amhara had lower Hb concentrations at both HA and LA (Table 
S2 and Figure S6 show that the differences were more than one gm/dL of Hb and more than one 
standard deviation). In contrast, Amhara had higher percent of O2 sat at HA than their Oromo 
counterparts. The result was similar for AOC among highlanders but a trend toward lower AOC among 
LA Amhara males that was statistically significant among Amhara females was observed. 
In summary, there were altitude and ethnic group differences in phenotypes with the Oromo 
showing a larger altitude response than the Amhara. 
 
Text S4. Comparing the genetic architecture of Hb levels between Ethiopian and Tibetans 
 
To compare the genetic architecture of Hb levels between Ethiopians and Tibetans [16,17,18], 
we performed association tests and power analyses at three levels: 1) the SNPs in EPAS1 and EGLN1 
associated with the trait in Tibetans, 2) all the SNPs within the same genes, and 3) all the SNPs within 
all the genes in the same pathway, i.e. response to hypoxia.  
The EPAS1 and EGLN1 SNPs that were previously associated with variation in Hb levels in 
Tibetans have effect sizes of 0.8 g/dL and 1.7 g/dL, respectively [16,17]. Of these SNPs, we considered 
those that were genotyped or imputed with greater than 90% accuracy in our Ethiopian data. Because the 
lack of association in the Ethiopians could be due to incomplete power, we calculated the probability of 
observing a significant association between SNP genotype and Hb levels in our data, assuming that the  
coefficient for each SNP is as high as or higher than that observed in Tibetans and using the 
corresponding MAF in the Ethiopians. As shown in Table 1, we have complete or nearly complete 
power to detect a genotype-phenotype association in our Ethiopian samples. This suggests that either the 
SNPs associated with variation in Hb levels in the Tibetans do not make a contribution in Ethiopians or 
if they do their phenotypic effect is smaller in Ethiopia. However, given their corresponding MAFs in 
Amhara, Oromo and Ethiopian, we have nearly complete power to detect a significant association even 
if the phenotypic effect was half as large as that observed in the Tibetan studies (Table S21). 
Next, we considered all SNPs within 10kb of the EPAS1 gene and repeated this analysis applying 
a Bonferroni correction for the number of tests performed (i.e., 72 SNPs). We find that we have greater 
than 95% power to detect a SNP with an effect size of at least 0.8 g/dL Hb concentration if the MAF in 
Ethiopia (Figure 3A) is greater than 10% (see Figure S16 for Amhara and Oromo). When we performed 
the same analysis for SNPs within 10kb of the EGLN1 gene (38 SNPs), we find that we had 100% 
power to detect SNPs with effect size of at least 1.7 g/dL Hb concentration if the SNP MAF in Ethiopia 
is greater than 5% (Figure 3B and Figure S16 for Oromo and Amhara). Because none of the EPAS1 or 
EGLN1 SNPs was significantly associated with Hb levels in Ethiopians after multiple test correction, 
this analysis suggests that genes shown to contribute to variation in Hb levels in Tibetans either do not 
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influence variation in the Ethiopian populations or if they do, their effect sizes are lower than those 
reported for the Tibetans. 
Finally, we considered the SNPs within 10kb of the candidate genes in the “Response to 
Hypoxia” GO category (26 genes). Because of the larger number of SNPs tested, this analysis has a 
relatively high multiple testing burden. Nonetheless, we find that we have greater than 80% power to 
detect a SNP significantly associated with Hb levels and effect size 0.8g/dL if its MAF is at least 20% 
and 100% power if its effect size is 1.7g/dL Hb (Figure 3C and Figure S16 for Oromo and Amhara).  
29 
 
SUPPORTING FIGURES 
 
 
 
 
Figure S1. FST-based neighbor-joining tree showing the relationships of the Ethiopians to the 
worldwide populations. Oromo and Amhara cluster closely together in the tree and occupy an 
intermediate position between African (with the exception of the Mozabites) and non-African 
populations. An ancestral population fixed for ancestral alleles at all SNPs was used.  
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Figure S2. Worldwide STRUCTURE plot. Each vertical line represents an individual, and the colors comprising each line 
correspond to the inferred proportion of ancestry from seven ancestral populations using 57652 random autosomal SNPs. 
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Figure S3. Scatter plot of the first two coordinates obtained by principal component analysis. A set of 
13,000 random autosomal SNPs were used. HA Amhara individuals are represented in red, LA Amhara 
in blue, HA Oromo in orange and LA Oromo in green. 
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Figure S4. Ethiopian STRUCTURE plot. Each vertical line represents an individual, and the colors 
comprising each line correspond to the inferred proportion of ancestry from three ancestral populations 
using 57652 random autosomal SNPs. Samples were ordered from left to right as follows: HA Amhara, 
LA Amhara, HA Oromo and LA Oromo. 
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Figure S5. Population differentiation among Ethiopian subgroups. The QQplots represent difference in allele frequency as 
summarized by FST between HA and LA Amhara (A), Oromo (B) and Ethiopia (C). The observed FST distribution is ranked from 
smallest to largest and plotted against the expected FST in black. The expected FST distribution was obtained by permuting the 
subgroup labels mimicking random mating. The grey area indicates the 95% confidence interval of the expected distribution (see 
Methods). 
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Figure S6. Altitude differences in anthropometric and phenotypic characteristics are summarized in the left two (gray) panels 
on terms of effect size d.  Ethnic differences are summarized in the right two (green) panels the same way.  D is dimensionless and is 
calculated as the difference between two sample means divided by their pooled standard deviation.  Comparison based on d values 
allows contrasting the altitude and ethnic-group differences in phenotypes independent of the units of measurement. By convention 
effect sizes of 0.8 or more are considered to be ‘large’ [89]. 
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Figure S7. Amhara Hb level and O2 sat GWAS results. The QQplot compares the observed –log10 
association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see Methods) for 
Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval.  The Manhattan plot shows 
the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D).  
 
36 
 
 
Figure S8. HA Amhara Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval.  The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S9. LA Amhara Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval.  The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S10. Oromo Hb level and O2 sat GWAS results. The QQplot compares the observed –log10 
association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see Methods) for 
Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The Manhattan plot shows 
the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S11. HA Oromo Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S12. LA Oromo Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S13. Ethiopia Hb level and O2 sat GWAS results. The QQplot compares the observed –log10 
association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see Methods) for 
Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The Manhattan plot shows 
the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S14. HA Ethiopia Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S15. LA Ethiopia Hb level and O2 sat GWAS results. The QQplot compares the observed –
log10 association p-value distribution (y-axis) with an expected distribution (x-axis) in black (see 
Methods) for Hb (A) and O2 sat (C). The grey area represents the 95% confidence interval. The 
Manhattan plot shows the observed –log10 association p-value of SNPs for Hb (B) and O2 sat (D). 
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Figure S16. Power plots. The effect of β and MAF on the power of association tests based on the Oromo (A-C) and Amhara (D-F) 
sample sizes (corrected for the number of SNPs tested within 10kb from gene) is illustrated for EPAS1 (A and D, 72 SNPs), EGLN1 
(B and E, 38 SNPs) and any gene within the Response to Hypoxia gene ontology category (C and F, 1309 SNPs). 
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Figure S17. Manhattan plots of PBS and MR transformed rank. Manhattan plots with SNPs with transformed rank less than 0.1 
are shown for Amhara PBS (vs. Maasai and Luyha) (A), for high altitude Amhara PBS (vs. low altitude Amhara and low altitude 
Oromo) (B), and high altitude Amhara MR (C). The transformed rank is the rank of the SNP in the corresponding distribution divided 
by the total number of SNPs. The horizontal line represents 0.001 transformed rank. 
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Figure S18. Multiple linear regression coefficients. This plot shows the regression coefficients of each 
of the 61 populations used to predict the expected allele frequencies in the HA Amhara in the multiple 
linear regression analysis.  Populations have been grouped in Africa, Middle East, Europe, Southwest 
Asia, East Asia, America and Oceania. In each group, populations have been ordered from larger to 
smaller coefficients. 
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Figure S19. Quantile-quantile (QQ) plots of methylation differentiation p-value. Each QQplot 
compares the observed methylation differentiation p-value distribution (y-axis) with the corresponding 
null distribution (x-axis) – which was created by reshuffling 100 times the altitude status among the 
compared samples and running the same lineal model. The grey area represents the 95 % confidence 
interval. No evidence of genome-wide HA vs. LA epigenetic adaptation was observed within Oromo (A) 
and Amhara (B). 
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Figure S20. Frequency distribution of imputation accuracy. SNPs with accuracy values less 
than 0.9 were removed from further analyses. 
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SUPPORTING TABLES 
 
SUPPLEMENTARY TABLES 
 
Table S1. Sample description for Amhara and Oromo high and low altitude (HA and LA) males and females (mean + SEM). 
 
 
Sample Subset N AGE (years) Height (cm) Weight (kg) BMI (kg/m
2
) Pulse (f/min) 
HA Amhara males 78 31 + 1 164.8 +  0.8 
**, b
 52.0 +  0.8 
**, b
  19.1 +  0.17 
**, b
 72.7 +  1.5 
LA Amhara males 48 34 + 1 
b
 171.1 +  0.9 58.3 +  0.8 
a
 19.9 +  0.24 
b
 75.7 + 1.5 
HA Amhara females 24 30 + 2 153.4 +  1.5 
a
 45.2 +  1.5 
**, b
 19.1 +  0.4 
+, c
 84.7 +  3.7 
LA Amhara females 12 29 +  3 152.3 +  3.7 
c
 52.8 +  2.3 23.4 +  1.9 84.1 +  3.5 
HA Oromo males 35 30 +  1 
**
 170.4 +  1.0 58.9 +  1.0 
*
 20.3 +  0.25 
**
 74.5 +  2.5 
LA Oromo males 27 25 +  1 172.2 +  1.1 55.4 +  1.0 18.7 +  0.28 73.6 +  2.2 
HA Oromo females 28 27 +  1 157.5 +  1.0  
*
 52.1 +  1.0 21.0 + 0.39 86.8 +  2.9 
LA Oromo females 8 26 +  2 161.9 +  1.6 55.7 +  2.9 21.3  +  1.33 86.5 +  2.6 
*
p < 0.05 t-test comparing same sex and ethnic group at high and low altitude 
**
P < 0.01 t-test comparing same sex and ethnic group at high and low altitude 
+
 0.05 < p < 0.01 t-test comparing same sex and ethnic group at high and low altitude 
a
 p < 0.05 t-test comparing Amhara and Oromo of the same sex at one altitude 
b
 P < 0.01 t-test comparing Amhara and Oromo of the same sex and ethnic group at one altitude 
c 
0.05 < p < 0.01 t-test comparing Amhara and Oromo of the same sex and ethnic group at one altitude 
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Table S2. Study phenotypes for Amhara and Oromo high and low altitude (HA and LA) males and females (mean + SEM). 
 
Sample Subset N Hb (gm/dL) O2 Sat (%) Arterial O2 content (mlO2/dL) 
HA Amhara males 72 16.8 +  0.13 
*, b
 92.4 +  0.4 
**, b
 21.5 + 0.19    
LA Amhara males 41 15.6 +  0.18 
b
 97.2 +  0.2 21.1 +  0.27 
c
 
HA Amhara females 21 14.8 +  0.24 
**, b
 93.8 +  0.6 
**, b
 19.4 + 0.32 
LA Amhara females 12 13.7 +  0.36 
a, +
 96.9 +  0.4 18.4 +  0.41 
a
 
HA Oromo males 35 18.5 +  0.31  
**, +
 86.7+  0.8 
**
 21.7 + 0.39 
LA Oromo males 27 16.7 +  0.22 97.1 +  0.2 21.7 +  0.33 
HA Oromo females 27 17.1 +  0.38
**
 84.9 +  0.7 
**
 20.1 +  0.34 
LA Oromo females 6 14.8 +  0.34 97.6 +  0.5 20.2 + 0.50 
*p < 0.05 t-test comparing same sex and ethnic group at high and low altitude 
**P < 0.01 t-test comparing same sex and ethnic group at high and low altitude 
+ 0.05 < p < 0.01 t-test comparing same sex and ethnic group at high and low altitude 
a
 p < 0.05 t-test comparing Amhara and Oromo of the same sex at one altitude 
b
 P < 0.01 t-test comparing Amhara and Oromo of the same sex and ethnic group at one altitude 
c 
0.05 < p < 0.01 t-test comparing Amhara and Oromo of the same sex and ethnic group at one altitude 
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Table S3. 20 SNPs with lowest Hb association p-values within Amhara. 
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs4949254 1 137 G -0.62 1.09E-05 20   
rs2019842 1 145 G 0.80 3.55E-07 3   
rs6700249 1 145 A 0.74 4.88E-07 4   
rs2184186 1 144 A 0.80 5.16E-07 6   
rs10737884 1 144 G 0.74 7.45E-07 7   
rs1855368 1 146 A 0.74 5.10E-07 5   
rs10803083 1 147 A 0.84 4.96E-08 1   
rs876912 1 143 G 0.78 1.79E-07 2   
rs1378539 2 131 A 0.65 8.02E-06 13   
rs12711718 2 147 A 0.62 8.69E-06 15   
rs4894345 3 146 G -0.58 9.60E-06 17  MRPS22,COPB2 
rs16854020 4 140 A -0.66 2.29E-06 9 CCDC4 SLC30A9 
rs16871658 5 132 A -0.85 8.56E-06 14   
rs5745616 7 147 A 0.64 1.03E-05 18 HGF  
rs2873896 8 133 A -0.74 1.06E-05 19   
rs2899662 15 147 A 0.91 8.16E-07 8 RORA  
rs17204475 15 139 A 0.89 2.65E-06 11 RORA  
rs13331158 16 136 A -0.66 2.42E-06 10  IRX5 
rs17805042 18 144 A 0.90 9.36E-06 16 MRO ME2,MAPK4 
rs13051923 21 147 G 0.68 2.72E-06 12  
COL6A2,FTCD,C21orf
56,COL6A1 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. In addition to age, sex, BMI (body mass index) and altitude, 
collection year was also used as covariate since samples were collected ten years apart. 
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Table S4. 20 SNPs with lowest oxygen saturation association p-values within Amhara.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs10496577 2 149 G -1.71 1.04E-05 18   
rs17279667 2 161 A -1.40 1.00E-05 16 MYO3B  
rs7659929 4 143 A -2.13 1.12E-06 3 ZNF721, PIGG ABCA11 
rs6446322 4 146 G -1.92 1.64E-07 1 STK32B CYTL1 
rs10518184 4 161 A 1.32 1.23E-06 4 FRAS1  
rs4859905 4 161 A 1.31 2.12E-06 5 FRAS1  
rs873455 4 160 A -1.08 6.97E-06 13 FRAS1  
rs157492 5 153 G -1.43 8.28E-06 14 GOLPH3 MTMR12,PDZD2 
rs11774254 8 154 G -1.86 4.57E-06 9   
rs17065459 8 161 G -1.70 1.15E-05 20   
rs10106108 8 161 A -1.26 1.06E-06 2   
rs11784218 8 159 A -1.60 3.77E-06 7   
rs4740840 9 151 G -1.13 4.34E-06 8 IL33 TPD52L3 
rs10904733 10 154 G -1.26 6.66E-06 12  PTER,C1QL3 
rs11253992 10 158 A 1.20 5.64E-06 11 PTER C1QL3 
rs12293066 11 161 A -1.68 1.02E-05 17   
rs1528635 11 161 G -1.32 1.05E-05 19   
rs2462165 11 146 A 1.20 4.66E-06 10   
rs416542 14 159 A 1.24 2.74E-06 6 GALC GPR65 
rs426633 19 161 A -1.09 8.71E-06 15 BRUNOL5 EDG6,NCLN,GNA15 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. In addition to age, sex, BMI (body mass index) and altitude, 
collection year was also used as covariate.  
53 
 
Table S5.  20 SNPs with lowest hemoglobin association p-values within high altitude Amhara.  
SNP Chr N A1  P Rank 
Genes 
(within 10kb) 
Genes (within 100kb) 
rs16854020 4 92 A -0.76 2.54E-06 1 CCDC4 SLC30A9 
rs13125215 4 94 A -0.66 2.63E-05 18   
rs4897037 6 86 G -0.82 1.71E-05 10  UST 
rs9329248 8 92 A 0.86 1.61E-05 9 GATA4,NEIL2 FDFT1,CTSB 
rs7829680 8 79 G -0.83 6.02E-06 2   
rs643273 11 86 A 1.12 1.20E-05 5  PLAC1L,MS4A2,MS4A3 
rs2730985 12 92 A -0.73 2.38E-05 14   
rs9315776 13 94 A -0.73 2.40E-05 16 LOC646982 LOC646982,FOXO1 
rs7494316 14 94 A -0.68 2.46E-05 17 AKAP6  
rs514438 15 92 G -0.85 1.47E-05 7 LCMT2, ADAL TUBGCP4,TP53BP1,ZSCAN29,TGM7,TGM5 
rs12911740 15 89 A -0.84 2.65E-05 19.5 TP53BP1 HISPPD2A,MAP1A,CKMT1B,TUBGCP4 
rs7177146 15 89 G -0.84 2.65E-05 19.5 TP53BP1 HISPPD2A,CKMT1B,STRC,MAP1A 
rs6493090 15 92 A -0.89 1.40E-05 6 
HYPK,SERINC4, hCG_1789710,PDIA3,WDR76,FRMD5, 
SERF2, ELL3 CATSPER2P1,MFAP1,CKMT1A 
rs678084 15 94 A -0.86 1.99E-05 11 MFAP1, WDR76 
FRMD5,CATSPER2P1,SERF2,PDIA3, 
hCG_1789710,SERINC4,HYPK,ELL3 
rs7174241 15 86 A -0.85 2.30E-05 13 WDR76 
HYPK,CATSPER2P1,SERF2,ELL3,PDIA3, 
SERINC4,FRMD5,MFAP1,hCG_1789710 
rs495880 15 82 G -0.89 2.39E-05 15 WDR76 
SERF2,ELL3,FRMD5,hCG_1789710, 
SERINC4,HYPK,MFAP1,PDIA3 
rs16962916 16 80 A 0.78 1.06E-05 4   
rs2298503 18 94 A 0.82 1.48E-05 8 RAB31  
rs1505267 21 83 G 0.70 2.23E-05 12 CHODL  
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. In addition to age, sex and BMI (body mass index), 
collection year was also used as covariate. 
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 Table S6. 20 SNPs with lowest oxygen saturation association p-values within high altitude Amhara.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs17011982 2 98 G -2.11 5.38E-06 15 BIRC6  
rs3731579 2 100 G -2.15 2.97E-06 6 BIRC6  
rs17429032 2 100 G -2.26 3.62E-06 9.5 BIRC6  
rs11683905 2 100 G -2.26 3.62E-06 9.5 BIRC6  
rs12465072 2 98 G -2.36 4.86E-06 12 BIRC6 TTC27 
rs17321135 2 98 G -1.89 7.15E-06 20 CNTNAP5  
rs7559515 2 99 A -1.88 7.02E-06 19 CNTNAP5  
rs1873393 3 92 G -3.05 6.95E-06 18 CHST13, C3orf22 UROC1,TR2IT1,ZXDC 
rs7659929 4 92 A -3.45 1.33E-07 1 PIGG, ZNF721 ABCA11 
rs6446322 4 94 G -2.38 6.68E-06 16 STK32B CYTL1 
rs10518184 4 101 A 1.80 4.96E-06 13 FRAS1  
rs157492 5 94 G -2.29 2.81E-06 4 GOLPH3 MTMR12,PDZD2 
rs9403279 6 98 G 1.79 3.21E-06 8   
rs719196 6 88 A 1.92 2.84E-06 5   
rs9376611 6 93 A 1.94 4.56E-06 11   
rs11774254 8 96 G -2.93 2.46E-06 3   
rs17065459 8 101 G -2.74 3.10E-06 7   
rs1528635 11 101 G -2.29 9.28E-07 2   
rs416542 14 99 A 1.80 5.13E-06 14 GALC GPR65 
rs8081452 17 101 A 1.85 6.78E-06 17  EFCAB3 
rs876912 1 91 G 0.77 1.04E-05 3   
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. In addition to age, sex and BMI (body mass index), 
collection year was also used as covariate.  
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Table S7. 20 SNPs with lowest hemoglobin association p-values within low altitude Amhara.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs6657602 1 49 G 2.05 1.03E-05 10 RYR2  
rs12105739 2 53 A -1.73 1.20E-05 13 ARHGAP15  
rs7612780 3 52 A 1.61 1.47E-05 18 OSBPL10  
rs6550509 3 53 G -1.12 6.29E-06 3 ITGA9 CTDSPL 
rs12152212 3 53 A 1.46 7.21E-06 6   
rs6813176 4 53 G 1.55 1.47E-06 1 FLJ46481 CRMP1,JAKMIP1 
rs210617 6 52 G 0.99 1.30E-05 16 DCBLD1, GOPC  
rs2071825 6 53 A 1.01 7.20E-06 5 DCBLD1,GOPC  
rs10457315 6 53 G 0.98 1.32E-05 17 DCBLD1,GOPC  
rs10872153 6 52 G 0.93 1.23E-05 14  DCBLD1, GOPC,NUS1 
rs4946273 6 53 G 0.92 1.80E-05 19  DCBLD1, GOPC,NUS1 
rs9489238 6 53 A 0.99 7.79E-06 7  DCBLD1, GOPC,NUS1 
rs1967194 6 53 G 0.92 1.08E-05 11  DCBLD1, GOPC,NUS1 
rs10087150 8 49 G 1.22 1.24E-05 15  CPA6 
rs7076094 10 53 G 1.18 4.35E-06 2 CTNNA3  
rs1971762 12 52 A 1.08 9.97E-06 9 ATP5G2 ATF7,CALCOCO1 
rs17056224 13 53 A 1.79 8.04E-06 8   
rs10852511 16 42 G 1.05 2.04E-05 20 PMFBP1 HP,HPR,TXNL4B,DHX38 
rs6063285 20 50 G -1.74 1.10E-05 12  PREX1 
rs17000823 21 42 G 1.04 6.51E-06 4 FAM3B MX2,BACE2,MX1 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex and BMI (body mass index) were used as 
covariates. 
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Table S8. 20 SNPs with lowest oxygen saturation association p-values within low altitude Amhara.  
 
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs1020470 3 55 A -1.04 6.40E-06 14 SCHIP1,IQCJ  
rs1873515 4 59 G -1.48 8.25E-07 2   
rs4735729 8 60 A -1.35 8.21E-06 18   
rs2490583 9 58 A -1.52 5.85E-06 12 RFK GCNT1 
rs2501920 9 60 A -1.45 5.95E-06 13  GCNT1,RFK 
rs7847608 9 58 G -1.50 6.60E-06 15 GCNT1 RFK 
rs6560519 9 60 G -1.51 4.23E-06 10 GCNT1 RFK 
rs12221280 10 47 G -1.20 2.28E-06 4 GPR158  
rs1352735 11 58 A -1.44 9.09E-07 3   
rs1982849 12 58 G -1.50 4.85E-06 11  PLCZ1,CAPZA3 
rs7980422 12 60 A -1.18 1.09E-05 20   
rs17116497 15 58 G -1.64 7.19E-06 16   
rs12323993 15 50 A -1.56 6.39E-07 1   
rs7172235 15 53 G -1.12 3.69E-06 8 PCSK6  
rs4502305 18 60 A -1.04 4.11E-06 9   
rs183049 19 59 A -1.16 2.88E-06 5.5 SLC6A16 FLJ32658,DKKL1,CD37,TEAD2 
rs659555 19 59 A -1.16 2.88E-06 5.5 CD37,SLC6A16 FLJ32658,TEAD2,DKKL1,PTH2 
rs35270176 19 54 A -1.36 3.27E-06 7 
LOC199800,CPT1C, AP2A1,SCAF1,IRF3,PRR12, 
PRMT1 RRAS,BCL2L12,TSKS,PRRG2 
rs159095 20 60 A -1.48 7.29E-06 17   
rs137994 22 59 G -1.21 8.50E-06 19 GRAP2 TNRC6B,ENTHD1,FAM83F 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex and BMI (body mass index) were used as 
covariates. 
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Table S9. 20 SNPs with lowest hemoglobin association p-values within Oromo.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs323937 1 94 A -0.98 1.46E-05 17   
rs6682943 1 94 A -0.98 1.56E-05 18   
rs1053413 2 94 G 1.31 5.22E-06 7.5 SLC35F5 RABL2A,RPL23AP7 
rs12624301 2 94 G 1.31 5.22E-06 7.5 SLC35F5 RABL2A 
rs4722321 7 91 A 1.08 1.59E-05 19   
rs11765705 7 94 A 1.42 6.77E-06 9 POU6F2  
rs834781 7 91 G -0.99 7.26E-06 10   
rs834787 7 93 G -1.19 9.61E-06 12   
rs2643268 8 81 G -1.30 1.60E-05 20   
rs780159 10 94 A 1.30 1.41E-05 15 ZMIZ1 LOC283050 
rs7120319 11 94 A 1.55 3.80E-06 4 OR51B6,OR51B5 
HBG1,HBBP1,OR51Q1,OR51I1, 
HBG2,OR51M1,OR51B2,HBE1,OR51B4 
rs12904003 15 94 G 0.96 2.19E-06 2  MFGE8,ACAN,HAPLN3 
rs7164649 15 90 G 0.98 3.37E-06 3  MFGE8,ACAN,HAPLN3 
rs7163586 15 90 G -0.98 4.42E-06 6  MFGE8,ACAN,HAPLN3 
rs12443377 15 84 G -0.97 1.37E-05 14  MFGE8,ACAN,HAPLN3 
rs12103697 17 94 A 1.39 7.87E-06 11 SMTNL2 GGT6,MYBBP1A,ALOX15,SPNS2,PELP1 
rs894621 17 94 G 1.38 1.81E-06 1 MSI2  
rs13306374 18 85 G 0.97 1.23E-05 13 GALR1  
rs7276366 21 91 A 1.28 1.45E-05 16   
rs135195 22 75 G -1.02 3.85E-06 5   
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index) and altitude were used as 
covariates. 
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Table S10. 20 SNPs with lowest oxygen saturation association p-values within Oromo.  
 
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs7592938 2 85 G -3.74 1.25E-05 14 CTNNA2  
rs4676890 3 98 A 2.48 8.91E-06 7   
rs164819 5 98 A -2.25 1.01E-05 10  TBCA 
rs2569340 5 98 A -2.81 7.62E-06 6 PHF15 SAR1B 
rs2589403 5 85 A -2.99 1.23E-05 13 PHF15 SAR1B,SEC24A 
rs7822400 8 98 A -2.62 5.34E-06 2 XKR6  
rs6985930 8 94 G -2.83 1.11E-05 11 OXR1  
rs10109202 8 98 A -2.54 1.27E-05 18   
rs4876526 8 98 A -2.54 1.27E-05 18   
rs4876528 8 98 A -2.54 1.27E-05 18   
rs2123385 8 94 A -2.54 8.97E-06 8   
rs10106553 8 98 G -2.54 1.27E-05 18   
rs1452757 8 98 G -2.78 6.92E-06 4.5   
rs4876314 8 98 A -2.54 1.27E-05 18   
rs10086147 8 98 A -2.78 6.92E-06 4.5   
rs902991 10 98 G 2.51 4.36E-06 1 NEURL SH3PXD2A 
rs3781366 10 95 A 2.32 1.18E-05 12 NEURL,SH3PXD2A  
rs12413931 10 98 A -3.05 6.24E-06 3 SH3PXD2A NEURL 
rs7102442 11 90 A 2.21 1.01E-05 9   
rs4784651 16 98 A -2.37 1.26E-05 15 GNAO1 DKFZP434H168,AMFR,LOC283856 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index) and altitude were used as 
covariates. 
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Table S11. 20 SNPs with lowest hemoglobin association p-values within high altitude Oromo.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs12063638 1 59 A 1.80 1.16E-05 10  PRDM2,PDPN 
rs323936 1 62 G -1.23 1.54E-05 14.5   
rs323937 1 62 A -1.23 1.54E-05 14.5   
rs6682943 1 62 A -1.24 1.74E-05 16   
rs6532200 4 52 A 1.48 2.25E-05 19 MMRN1 SNCA 
rs12189506 5 58 G 1.55 2.39E-05 20   
rs2108288 7 62 A 1.63 1.52E-05 13 RAPGEF5  
rs11765705 7 62 A 1.81 5.87E-06 4 POU6F2  
rs721123 7 62 G 1.82 1.11E-06 1 CNTNAP2  
rs1997560 8 62 A 1.60 5.91E-06 5  GDAP1,JPH1 
rs1350172 10 51 G 1.39 1.31E-06 2  C10orf107 
rs780159 10 62 A 1.63 9.58E-06 9 ZMIZ1 LOC283050 
rs780151 10 60 A 1.60 2.10E-05 18 ZMIZ1  
rs7120319 11 62 A 2.06 2.62E-06 3 OR51B6,OR51B5 
HBG1,HBBP1,OR51Q1,OR51I1, 
HBG2,OR51M1,OR51B2,HBE1,OR51B4 
rs11038860 11 57 G 1.40 9.26E-06 7 CREB3L1 MDK,AMBRA1,CHRM4,DGKZ 
rs7476 11 62 A 1.30 1.36E-05 12 CREB3L1 MDK,AMBRA1,CHRM4,DGKZ 
rs10129651 14 51 A 1.36 1.29E-05 11  SERPINA13,GSC,SERPINA3 
rs3744793 17 62 A -1.32 9.27E-06 8 USP36 TIMP2,PSCD1 
rs135195 22 48 G -1.33 8.23E-06 6   
rs138978 22 58 G -1.29 1.78E-05 17 SCUBE1 TSPO,TTLL12,BIK,MCAT 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested.  Age, sex and BMI (body mass index) were used as 
covariates. 
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Table 12. 20 SNPs with lowest oxygen saturation p-values within high altitude Oromo.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs9557 1 48 G -4.491 3.73E-06 4 MAN1A2 FAM46C 
rs36235 3 58 A -3.698 3.97E-06 5 PRICKLE2 PSMD6 
rs7650033 3 58 A -4.654 2.79E-06 2  SUCLG2 
rs1173228 5 63 A -3.468 9.35E-06 11   
rs1392411 5 63 G -3.987 1.04E-05 12   
rs164819 5 63 A -3.43 1.30E-05 17  TBCA 
rs2569340 5 63 A -3.676 1.17E-05 13 PHF15 SAR1B 
rs4580847 6 55 A -4.749 2.26E-06 1  LRFN2 
rs11786531 8 61 G -4.29 9.30E-06 10  IMPAD1 
rs9297382 8 59 G -3.395 8.17E-06 8 OXR1  
rs6985930 8 60 G -4.439 2.87E-06 3 OXR1  
rs2123385 8 59 A -3.535 1.31E-05 18   
rs1452757 8 63 G -3.647 1.17E-05 14.5   
rs10086147 8 63 A -3.647 1.17E-05 14.5   
rs7067934 10 63 A -5.298 5.60E-06 6 SH2D4B TSPAN14 
rs613587 11 63 G -4.361 8.90E-06 9 FLI1 KCNJ1 
rs4150282 13 62 A 3.598 1.33E-05 20 ERCC5 C13orf27,LOC121952,BIVM,KDELC1 
rs904864 15 63 G -4.063 6.55E-06 7  NOX5,TMEM84,GLCE 
rs1345856 16 48 A -4.063 1.31E-05 19   
rs6075602 20 63 G -3.775 1.20E-05 16 RIN2 NAT5,CRNKL1,C20orf26 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex and BMI (body mass index) were used as 
covariates. 
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Table S13. 20 SNPs with lowest hemoglobin p-values within low altitude Oromo.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs4553221 1 32 A 1.591 2.63E-05 17 CAMTA1  
rs696119 1 32 A -1.395 3.65E-06 5 C1orf173 CRYZ,TYW3 
rs13405506 2 32 A -1.158 1.19E-06 3 RAMP1 RBM44,UBE2F,LRRFIP1,SCLY 
rs2168494 4 31 A 1.748 1.45E-05 11.5   
rs959628 4 31 A 1.748 1.45E-05 11.5   
rs1378923 4 30 A 1.748 2.14E-05 16   
rs6842580 4 32 G 1.528 3.60E-06 4   
rs17343168 5 32 G 1.806 5.22E-06 6   
rs10484824 6 32 G 1.346 3.88E-07 1 KIF6  
rs10456473 6 32 A 1.193 9.44E-07 2 KIF6  
rs6458179 6 32 G 0.9942 9.63E-06 8   
rs4548215 8 32 G 1.288 8.68E-06 7   
rs3737147 9 32 G 1.764 1.46E-05 13.5 NOL8,CENPP OGN,OMD,IARS,SNORA84 
rs7872423 9 32 G 1.764 1.46E-05 13.5 NOL8,CENPP OGN,OMD,IARS,SNORA84 
rs10999916 10 28 A 1.477 2.64E-05 18 CDH23  
rs1327314 13 29 G 1.334 2.80E-05 19   
rs1077918 15 32 A 1.826 1.69E-05 15 VPS18 
RHOV,DLL4,CHAC1,INOC1, 
SPINT1,ZFYVE19,PPP1R14D 
rs1261084 18 31 A 1.074 1.28E-05 9 TCF4  
rs5755469 22 25 G 1.377 1.33E-05 10  ISX 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex and BMI (body mass index) were used as 
covariates. 
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Table S14. 20 SNPs with lowest oxygen saturation p-values within low altitude Oromo.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs12088462 1 35 A -1.93 6.56E-06 4 SLC44A5  
rs4598448 1 34 A -1.93 2.02E-05 19 SLC44A5  
rs1999493 1 34 G -1.91 1.10E-05 9 SLC44A5  
rs9819197 3 35 A -1.88 6.60E-06 5   
rs149473 5 35 G -1.12 4.39E-06 2   
rs12662109 6 35 G -1.67 5.82E-06 3   
rs17128582 8 34 G -1.89 9.01E-06 8 ChGn  
rs16912021 9 35 A -1.36 1.26E-05 10 FANCC C9orf3 
rs12574036 11 33 A -1.56 1.92E-05 17 LUZP2  
rs2512637 11 35 G -1.65 1.74E-05 15  ODZ4 
rs10774174 12 35 G -1.41 1.27E-05 12.5 PARP11 EFCAB4B 
rs12424633 12 35 A -1.41 1.27E-05 12.5 PARP11 EFCAB4B 
rs7965615 12 35 A -1.41 1.27E-05 12.5 PARP11 EFCAB4B 
rs11062846 12 35 A -1.41 1.27E-05 12.5 PARP11 EFCAB4B 
rs3825374 12 34 A -1.51 1.24E-06 1 PARP11 EFCAB4B 
rs11829730 12 33 G -1.70 8.90E-06 7 SOX5  
rs9520256 13 35 G 1.14 1.95E-05 18   
rs4414463 15 35 A 1.14 8.73E-06 6 CSPG4 SNUPN,ODF3L1,SH3PX3,IMP3 
rs16950701 18 35 A -1.38 2.14E-05 20 LIPG  
rs6038686 20 33 G -1.96 1.88E-05 16   
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex and BMI (body mass index) were used as 
covariates. 
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Table S15. 20 SNPs with lowest hemoglobin p-values within total Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs1574106 1 238 A -0.52 1.54E-05 15  TINAGL1,SERINC2,LOC284551 
rs11811630 1 241 A -0.58 1.66E-05 17 NCF2 APOBEC4,SMG7,RGL1,ARPC5 
rs17453871 2 220 A 0.65 9.72E-06 9  YWHAQ,ADAM17 
rs2742347 2 223 A -0.66 1.60E-05 16 TTN CCDC141 
rs2627037 2 222 A -0.61 7.30E-06 8 TTN CCDC141 
rs7590740 2 226 G -0.70 1.07E-05 11 TTN CCDC141 
rs6556187 5 241 G 0.85 2.49E-06 4   
rs6978495 7 241 G 0.50 1.72E-05 18 PDE1C  
rs1062831 7 230 G 0.70 5.45E-06 7 RELN SLC26A5 
rs4147310 8 241 G 0.53 1.23E-05 13   
rs7068383 10 201 G -0.60 1.42E-05 14 KIAA1217 KIAA1217 
rs6480379 10 241 G 0.54 1.01E-05 10  DDX21,SRGN,VPS26A,KIAA1279 
rs4745975 10 232 G 0.62 1.38E-06 1  DDX21,SRGN,VPS26A,KIAA1279 
rs1524250 12 226 G -0.54 1.77E-05 19 CNOT2 KCNMB4 
rs2619133 12 196 A 0.56 1.92E-05 20  SPIC,MYBPC1 
rs4424941 17 236 A 0.65 3.75E-06 6  PRKCA,CCDC46,APOH 
rs4305120 17 237 A 0.64 3.60E-06 5  PRKCA,CCDC46,APOH 
rs8081614 17 241 G 0.66 1.63E-06 2  PRKCA,CCDC46,APOH 
rs16959046 17 241 G 0.75 2.24E-06 3 PRKCA APOH 
rs440624 21 226 G -0.75 1.21E-05 12 CHODL  
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year, altitude 
and ethnicity were used as covariates. 
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Table S16. 20 SNPs with lowest oxygen saturation p-values within total Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs12733615 1 259 A 1.24 7.85E-06 7  UHMK1,UAP1,FLJ13137,SH2D1B 
rs4675041 2 259 A -1.39 8.70E-06 9   
rs6802224 3 246 G 1.29 3.85E-06 3   
rs7703046 5 253 G -1.36 8.07E-06 8   
rs11738661 5 256 A -1.30 1.47E-05 19   
rs337715 5 259 G -1.43 1.16E-05 15 KCNN2  
rs1803989 6 258 A -1.73 1.38E-05 18 LOC729603, IGF2R SLC22A2,SLC22A1 
rs1035153 7 259 A -1.52 9.26E-06 10   
rs6996198 8 259 A -1.25 9.28E-06 11  BHLHB5,CYP7B1,LOC401463 
rs10104685 8 255 G -1.40 1.08E-05 14   
rs2123385 8 252 A -1.43 1.02E-05 12   
rs1452757 8 259 G -1.51 1.28E-05 16.5   
rs10086147 8 259 A -1.51 1.28E-05 16.5   
rs6420192 8 258 A -1.38 3.90E-06 4 
 PARP10,NRBP2,SCRIB,EPPK1, 
 PLEC1,PUF60,GRINA 
rs12380152 9 254 A -1.57 1.57E-05 20 PTPRD  
rs10869434 9 246 A 1.40 2.39E-06 2 PIP5K1B FAM122A,PIP5K1B 
rs17392931 9 251 G 1.29 4.60E-06 5 PIP5K1B FAM122A,PIP5K1B 
rs11144066 9 245 G 1.35 2.12E-06 1 PIP5K1B FAM122A,PIP5K1B 
rs11857947 15 234 A 1.34 5.70E-06 6 CIB2 IDH3A,ACSBG1,TBC1D2B,hCG_38941 
rs176096 17 253 A 1.34 1.04E-05 13 FLJ45455  
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year, altitude 
and ethnicity were used as covariates. 
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Table S17. 20 SNPs with lowest hemoglobin p-values within the total high altitude Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs1880418 1 147 A 0.71 1.49E-05 6   
rs7548781 1 154 A 0.87 3.19E-05 17.5 HSD11B1 
LAMB3,TRAF3IP3,C1orf107, 
G0S2,C1orf74,IRF6 
rs13400823 2 140 A -0.72 2.29E-05 14 MYT1L  
rs2624520 5 141 A 0.95 2.08E-05 13   
rs1586656 6 156 G 1.05 2.94E-05 15 EGFL11  
rs7801660 7 156 A 0.81 1.92E-05 11 POU6F2  
rs6952464 7 155 A 0.79 3.41E-05 19 POU6F2  
rs11765705 7 156 A 1.05 4.65E-06 2 POU6F2  
rs10951593 7 148 A 1.09 1.01E-05 3 POU6F2  
rs10260368 7 156 G -0.78 1.48E-05 5 ST7OT2,ST7  
rs4627213 13 155 A 1.10 3.61E-06 1   
rs2322233 13 150 G 1.05 1.15E-05 4   
rs10129651 14 135 A 0.74 1.83E-05 8  SERPINA3,GSC,SERPINA13 
rs915378 14 155 A 0.76 2.06E-05 12   
rs4842899 15 144 A 0.81 1.87E-05 10  KLHL25,AKAP13 
rs7164649 15 145 A -0.65 3.19E-05 17.5  ACAN,HAPLN3,MFGE8 
rs7163586 15 149 G -0.66 3.04E-05 16  HAPLN3,MFGE8,ACAN 
rs16959046 17 156 G 0.89 1.72E-05 7 PRKCA APOH 
rs681307 18 155 A -0.69 1.86E-05 9   
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year and 
ethnicity were used as covariates. 
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 Table S18. 20 SNPs with lowest oxygen saturation p-values within the total high altitude Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs6751526 2 164 G -2.32 1.48E-05 18   
rs7438763 4 162 G 2.08 1.54E-05 20 LRIT3,RRH EGF,NOLA1,CFI 
rs1990250 4 156 G 2.30 5.97E-06 10 LRIT3,RRH EGF,NOLA1,CFI 
rs13160737 5 148 G -2.27 1.18E-05 15 ZFR MTMR12 
rs9464002 6 162 A -2.68 2.16E-06 1 LRRC1 C6orf142 
rs6937549 6 164 A -2.50 1.08E-05 14 C6orf176  
rs10269222 7 164 A -2.15 1.19E-05 16 SDK1  
rs10104685 8 160 G -1.99 4.15E-06 4   
rs2123385 8 158 A -2.08 2.63E-06 2   
rs1452757 8 164 G -2.09 5.82E-06 8.5   
rs10086147 8 164 A -2.09 5.82E-06 8.5   
rs6986020 8 164 G -1.83 1.24E-05 17   
rs11144066 9 154 G 1.72 1.50E-05 19 PIP5K1B FAM122A,PIP5K1B 
rs602347 11 141 A 2.09 4.78E-06 5 EHD1 
MEN1,ATG2A,MAP4K2,GPHA2, 
LOC283129,PPP2R5B,CDC42BPG 
rs1647105 12 164 A 1.64 1.07E-05 13   
rs11857947 15 144 A 1.83 5.41E-06 7 CIB2 IDH3A,ACSBG1,TBC1D2B,hCG_38941 
rs10775410 17 164 A -1.64 7.45E-06 12 MYO1D CDK5R1,PSMD11 
rs7263002 20 164 G -2.62 6.28E-06 11 SNRPB,SNORD119 TMC2,ZNF343,TGM6 
rs6114384 20 164 A -2.63 5.22E-06 6 SNRPB,SNORD119 TMC2,ZNF343,TGM6 
rs8114620 20 159 G -2.63 2.65E-06 3 SNRPB,SNORD119 TMC2,ZNF343,TGM6 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year and 
ethnicity were used as covariates. 
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Table S19. 20 SNPs with lowest hemoglobin p-values within the total low altitude Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs12119834 1 85 A 0.98 1.39E-05 11 PCTK3 ELK4,MFSD4,LOC284578,LEMD1 
rs10510829 3 85 G 1.22 1.78E-05 14 FHIT  
rs11711620 3 85 G 1.31 1.09E-06 1 ZBTB20  
rs1506792 4 82 A 1.06 1.11E-05 9   
rs1506791 4 73 A 1.21 1.01E-05 8   
rs4146409 4 85 A -0.92 2.54E-06 2   
rs11944671 4 85 A -0.92 8.30E-06 5   
rs1363073 5 85 A 1.12 1.54E-05 12   
rs13195572 6 85 G 1.16 2.45E-05 19.5  C6orf138 
rs13198330 6 85 G 1.16 2.45E-05 19.5  C6orf138 
rs11992396 8 80 A 1.09 1.79E-05 16 PSD3  
rs1447293 8 85 A 0.90 8.77E-06 6 LOC727677 POU5F1P1 
rs11142705 9 85 A 0.89 1.25E-05 10 TRPM3  
rs12351692 9 77 A 1.35 9.03E-06 7 CORO2A,TRIM14 TBC1D2,NANS 
rs10788462 10 85 A 1.25 1.91E-05 17 GRID1  
rs2928011 10 84 A 1.17 1.78E-05 15 GRID1  
rs7919376 10 84 A 1.24 2.38E-05 18 GRID1  
rs4757615 11 84 A -0.84 7.40E-06 3 SAAL1 MRGPRX4,TPH1,SERGEF,MRGPRX3,SAA3P 
rs734309 16 84 A -0.85 1.60E-05 13 GPT2 LOC388272,DNAJA2 
rs6089316 20 80 A 0.82 8.30E-06 4 TAF4 PSMA7,SS18L1,LSM14B 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year and 
ethnicity were used as covariates. 
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Table S20. 20 SNPs with lowest oxygen saturation p-values within the total low altitude Ethiopian sample.  
SNP Chr N A1  P Rank Genes (within 10kb) Genes (within 100kb) 
rs6690390 1 95 A 1.16 8.52E-06 8   
rs11582141 1 95 G 0.97 8.61E-06 9   
rs2792251 1 95 G 0.84 1.42E-05 14 PBX1  
rs4551629 1 74 G -1.20 7.85E-06 7 
 LOC441931,ZNF496,ZNF124, 
 VN1R5,FLJ45717 
rs7581685 2 90 G -1.00 1.82E-05 19  SPAG16 
rs10458166 6 95 G -0.93 1.17E-05 11 PRPF4B C6orf146,C6orf201 
rs980962 6 91 G -1.15 8.51E-07 2 ZNF391 FKSG83,ZNF184,ZNF204 
rs9373984 6 76 G 0.88 5.88E-06 5 SCML4 SEC63 
rs7784712 7 90 A -0.98 1.78E-05 17  HDAC9,TWIST1 
rs2392591 7 90 A -0.82 6.03E-06 6  AMPH,LOC340286,VPS41 
rs16890858 8 95 A -1.04 8.80E-06 10 SAMD12  
rs10988467 9 95 A -0.80 4.83E-06 4 PRRX2 C9orf32,ASB6,C9orf50,PTGES 
rs10786940 10 85 G 0.95 1.89E-05 20   
rs7970151 12 95 A -1.21 1.78E-05 18   
rs8038032 15 90 G 0.82 1.50E-05 15  ZNF770,AQR,hCG_1787519 
rs11083340 18 95 A -0.86 1.61E-05 16   
rs4369752 18 88 A -0.88 2.16E-06 3   
rs183049 19 92 A -0.88 1.41E-05 13 SLC6A16 FLJ32658,DKKL1,TEAD2,CD37 
rs659555 19 91 A -0.90 1.25E-05 12 SLC6A16,CD37 FLJ32658,DKKL1,TEAD2,PTH2 
rs35270176 19 89 A -1.27 1.73E-07 1 LOC199800,CPT1C,PRMT1 
AP2A1,SCAF1,IRF3,PRR12, 
RRAS,BCL2L12,TSKS,PRRG2 
Only SNPs with MAF <10% and imputation accuracy > 0.9 were tested. Age, sex, BMI (body mass index), collection year and 
ethnicity were used as covariates. 
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Table S21. Power calculations within the Ethiopian samples.  
  Tibetans
1
 Amhara Oromo Ethiopia 
SNP Gene  half 
3 N MAF Power3 N MAF Power3 N MAF Power3 
rs961154 EGLN1 1.70 0.85 141 0.39 100 92 0.41 100 233 0.40 100 
rs2790859 EGLN1 1.70 0.85 141 0.39 100 92 0.41 100 233 0.40 100 
rs1992846 EPAS1 0.84 0.42 124 0.36 90 78 0.42 74 202 0.38 99 
rs7594278 EPAS1 0.52 0.26 131 0.31 49 77 0.24 27 208 0.28 66 
rs6544887 EPAS1 0.79 0.40 130 0.34 86 86 0.34 70 216 0.34 98 
rs17035010 EPAS1 0.84 0.42 136 0.39 93 85 0.30 72 221 0.36 99 
rs3768729 EPAS1 0.80 0.40 133 0.44 91 86 0.44 75 219 0.44 99 
rs7583554 EPAS1 0.94 0.47 138 0.46 98 90 0.41 89 228 0.44 100 
rs7583088 EPAS1 0.92 0.46 144 0.30 96 94 0.22 75 238 0.27 100 
rs11678465 EPAS1 0.85 0.43 144 0.30 92 93 0.22 67 237 0.27 99 
rs6712143 EPAS1 0.94 0.47 145 0.40 98 92 0.32 86 237 0.37 100 
rs4953342 EPAS1 0.90 0.45 147 0.21 89 94 0.12 52 241 0.18 97 
rs2121266 EPAS1 1.02 0.51 147 0.38 99 94 0.30 91 241 0.35 100 
rs9973653 EPAS1 0.52 0.26 147 0.35 57 94 0.30 37 241 0.33 77 
rs1374749 EPAS1 0.88 0.44 147 0.47 97 94 0.49 87 241 0.48 100 
rs4953353 EPAS1 0.97 0.49 147 0.31 98 94 0.31 88 241 0.31 100 
rs6756667 EPAS1 0.93 0.47 147 0.37 98 94 0.32 86 241 0.35 100 
rs7571218 EPAS1 0.71 0.36 147 0.50 87 94 0.49 69 241 0.50 98 
 
1
 Genotype-phenotype association beta coefficients for EGLN1 were obtained from Simonson et al [16] while those for EPAS1 were 
obtained from Beall et al [17]. 
2
  indicates the observed linear coefficient for the relationship between SNP genotype and Hb levels. 
3
 half  indicates half of the observed linear coefficient for the relationship between SNP genotype and Hb levels. 
3
 Power refers to the probability of detecting a significant association (p<0.05) between SNP genotype and Hb level given the MAF 
and the sample size in the Ethiopian populations assuming that the  coefficient is higher than half of the observed in Tibetan
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Table S22. Proportions of Response to Hypoxia genic SNPs relative to the proportion of all other genic 
SNPs in the tails of the PBS distributions for each population trio tested. * and ** denote support from ≥ 
95% and 99% of bootstrap replicates, respectively. 
 
Populations 
Hypoxia genes : all other genes 
PBS tail cut-off 
A B C 0.005 0.01 0.05 
Amhara Maasai Luhya 3.40* 3.41** 1.84* 
Amhara Maasai Yoruba 3.432 3.058* 1.929 
Amhara LA Oromo HA Oromo 2.628 1.951 2.203* 
Amhara Luhya Europe 1.899 2.074 1.468 
Amhara Luhya Yoruba 1.151 2.502 1.586 
Amhara Maasai Europe 1.862 2.124 1.406 
HA Amhara LA Amhara LA Oromo 3.31 2.90 1.92* 
HA Amhara LA Amhara Oromo 2.215 2.003 1.557 
HA Amhara LA Amhara Yoruba 1.029 1.843 2.03** 
HA Amhara LA Amhara Maasai 1.675 2.147 1.774 
HA Amhara LA Amhara Europe 2.297 1.619 1.121 
HA Amhara LA Amhara Luhya 0.585 1.167 2.088* 
LA Amhara HA Oromo LA Oromo 1.174 1.528 1.149 
LA Amhara HA Amhara Oromo 0.897 0.81 1.131 
LA Amhara HA Amhara Maasai 1.172 0.995 0.944 
LA Amhara HA Amhara Europe 1.112 0.678 1.026 
LA Amhara HA Amhara Luhya 1.215 0.608 0.939 
LA Amhara HA Amhara Yoruba 1.134 0.567 0.778 
LA Amhara HA Amhara LA Oromo 0.69 0.704 0.895 
Ethiopia Maasai Yoruba 3.991 3.162* 1.578 
Ethiopia Luhya Europe 3.458 2.334 1.226 
Ethiopia Luhya Yoruba 1.358 1.675 1.581 
Ethiopia Maasai Europe 1.184 1.169 1.077 
HA Ethiopia LA Ethiopia Yoruba 2.105 2.367* 1.442* 
HA Ethiopia LA Ethiopia Luhya 0.551 1.378 1.747* 
HA Ethiopia LA Ethiopia Maasai 1.128 0.824 1.323 
HA Ethiopia LA Ethiopia Europe 0.584 0.82 0.971 
LA Ethiopia HA Ethiopia Europe 1.104 1.077 1.247 
LA Ethiopia HA Ethiopia Yoruba 1.756 1.164 0.653 
LA Ethiopia HA Ethiopia Maasai 1.132 0.891 0.9 
LA Ethiopia HA Ethiopia Luhya 1.18 1.176 0.687 
Europe Luhya Oromo 1.74 1.917 1.542 
Europe LA Oromo HA Oromo 2.062 1.463 1.769* 
Europe Maasai Oromo 1.071 2.039 1.737 
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Europe LA Ethiopia HA Ethiopia 1.695 1.364 1.332 
Europe Luhya Ethiopia 0.001 1.558 1.411 
Europe Luhya Amhara 0.044 1.149 1.448 
Europe LA Amhara HA Amhara 0.199 1.303 1.213 
Europe Maasai Ethiopia 0.008 1.173 1.375 
Europe Maasai Amhara 0 1.11 1.39 
Luhya LA Amhara HA Amhara 2.274 1.675 1.55 
Luhya LA Ethiopia HA Ethiopia 2.317 1.686 1.357 
Luhya Ethiopia Europe 1.202 1.923 1.741 
Luhya Amhara Europe 1.174 1.693 1.818* 
Luhya Oromo Europe 1.722 1.431 1.286 
Luhya Amhara Yoruba 1.667 2.068 1.494 
Luhya LA Oromo HA Oromo 1.952 1.513 1.222 
Luhya Ethiopia Yoruba 1.13 1.4 1.363 
Luhya Oromo Yoruba 0.881 1.388 1.38 
Luhya Maasai Amhara 0.457 1.151 0.953 
Luhya Maasai Oromo 0.516 0.584 0.888 
Maasai Amhara Europe 3.022 2.468 1.704 
Maasai LA Amhara HA Amhara 4.125 3.497* 1.706 
Maasai Ethiopia Europe 1.851 2.408 1.59 
Maasai LA Ethiopia HA Ethiopia 2.343 2.645 1.542 
Maasai LA Oromo HA Oromo 4.41 2.683 0.964 
Maasai Oromo Europe 1.541 1.408 1.377 
Maasai Amhara Yoruba 1.675 1.122 1.202 
Maasai Ethiopia Yoruba 1.746 0.873 1.048 
Maasai Amhara Luhya 1.753 1.144 0.821 
Maasai Oromo Yoruba 1.689 1.127 0.824 
Maasai Oromo Luhya 1.194 0.785 0.972 
Oromo LA Amhara HA Amhara 2.69 2.19 2.114** 
Oromo Maasai Luhya 2.988 1.756 1.445 
Oromo Maasai Yoruba 3.464 2.002 1.038 
Oromo Luhya Europe 1.261 1.719 1.165 
Oromo Luhya Yoruba 0.916 1.391 1.116 
Oromo Maasai Europe 1.175 1.261 0.936 
HA Oromo LA Amhara LA Oromo 1.858 1.567 1.155 
HA Oromo LA Oromo Amhara 1.324 1.857 0.835 
HA Oromo LA Oromo Europe 0.502 1.622 1.161 
HA Oromo LA Oromo Yoruba 0.001 1.353 1.089 
HA Oromo LA Oromo Maasai 0.606 0.913 0.993 
HA Oromo LA Oromo Luhya 0.53 0.266 1.159 
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LA Oromo HA Oromo Europe 2.869 1.972 1.355 
LA Oromo HA Oromo Yoruba 3.754 1.903 1.162 
LA Oromo HA Oromo Amhara 1.999 1.558 1.166 
LA Oromo HA Oromo Maasai 1.671 1.478 1.064 
LA Oromo LA Amhara HA Amhara 0.219 1.189 1.393 
LA Oromo LA Amhara HA Oromo 0.889 0.898 0.837 
LA Oromo HA Oromo Luhya 0.53 0.266 1.159 
Yoruba LA Ethiopia HA Ethiopia 1.588 1.309 1.587 
Yoruba LA Amhara HA Amhara 1.057 2.15 1.617 
Yoruba LA Oromo HA Oromo 2 1.259 1.32 
Yoruba Maasai Amhara 1.71 1.092 1.312 
Yoruba French Oromo 0.532 1.703 1.808 
Yoruba Maasai Ethiopia 1.597 1.077 1.227 
Yoruba Maasai Oromo 1.597 0.799 1.213 
Yoruba Luhya Ethiopia 2.149 1.074 0.773 
Yoruba Luhya Oromo 2.2 1.1 0.737 
Yoruba Luhya Amhara 2.181 1.091 0.739 
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Table S23. List of the 20 SNPs with the largest Amhara PBS (vs. Maasai and Luya).  
 
SNP Chr Nt. pos. Rank Gene (within 10kb) Gene (within 100kb) 
rs619660 3 43002953 2 LOC729085 C3orf39,ZNF662,CCBP2 
rs9853065 3 174475785 5 NA NA 
rs6994475 8 1260833 3 NA NA 
rs6558447 8 1261463 9 NA NA 
rs2357735 8 115943237 13 NA NA 
rs10112994 8 116016470 14 NA NA 
rs1888076 9 72945254 17 TRPM3 TRPM3 
rs7860423 9 140075368 4 CACNA1B NA 
rs11137360 9 140077378 12 CACNA1B NA 
rs7940567 11 7078885 1 RBMXL2 ZNF214,NLRP14 
rs4375446 11 66667402 10 FBXL11 RHOD,SYT12 
rs674499 11 66720001 11 FBXL11 ANKRD13D,ADRBK1 
rs4542419 11 66727173 6 FBXL11 ANKRD13D,ADRBK1 
rs3927807 11 66755431 8 FBXL11 SSH3,ADRBK1,ANKRD13D 
rs1638566 11 66880909 15.5 POLD4,CLCF1 
PTPRCAP,CORO1B,GPR152,TBC1D10C,KIAA1394,RPS6KB2 
CABP4,PPP1CA,ADRBK1,ANKRD13D,SSH3,RAD9A,FBXL11 
rs1638567 11 66881799 15.5 POLD4,CLCF1 
PTPRCAP,CORO1B,GPR152,TBC1D10C,KIAA1394,RPS6KB2 
CABP4,PPP1CA,ADRBK1,ANKRD13D,SSH3,RAD9A,FBXL11 
rs10842162 12 23444386 7 NA NA 
rs735480 15 42939663 19 NA TRIM69,C15orf43 
rs1011489 16 5607394 18 NA NA 
rs2306192 19 14004016 20 IL27RA,RLN3 LOC113230,PRKACA,ASF1B,SAMD1,PODNL1,LOC90379,RFX1 
Only SNPs with imputation accuracy > 0.9 were tested.  
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Table S24. 20 SNPs with largest high altitude Amhara PBS (versus low altitude Amhara and low altitude Oromo).  
SNP Chr Nt. pos. Rank Genes (within 10kb) Genes (within 100kb) 
rs2814778 1 157441307 2 DARC,CADM3 FCER1A 
rs1487529 1 192399145 12   
rs10863766 1 204892228 17 DYRK3 LGTN,RASSF5,MAPKAPK2 
rs7539843 1 242957549 5  FAM152A,C1orf101 
rs10180234 2 153095625 11 FMNL2  
rs349003 2 222660565 10   
rs349010 2 222663592 14   
rs3768889 2 225073300 3 CUL3 FAM124B 
rs13181143 5 140186928 9 
PCDHA1, PCDHA2, PCDHA3,  PCDHAC1,PCDHA8,PCDHA9, 
 PCDHA4, PCDHA5,  PCDHA10,PCDHA11, 
PCDHA6, PCDHA7 PCDHA12,PCDHA13 
rs4377754 5 153096868 16 GRIA1  
rs7764351 6 32529609 1 HLA-DRA HLA-DRB5,BTNL2,HLA-DRB1,C6orf10,HLA-DRB6 
rs7753021 6 145310595 19  UTRN 
rs10094452 8 117810022 15 EIF3H C8orf53 
rs2048803 12 57841104 18   
rs1983521 14 21688320 20   
rs16940947 18 20533441 13   
rs10416242 19 13611618 4  CCDC130 
rs1422837 19 13615667 6  CCDC130 
rs398717 21 42874233 7 SLC37A1 PDE9A,SLC37A1,RSPH1 
rs133352 22 40763968 8 WBP2NL 
NDUFA6,CYP2D6,NAGA,FAM109B, 
C22orf32,LOC339674,CENPM,SEPT3 
Only SNPs with imputation accuracy > 0.9 were tested. 
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Table S25. SNPs with oxygen saturation (O2 Sat) association p-value < 0.05 among the top 20 Amhara PBS SNPs. 
 
Test1 Test1 SNP Chr Nt. pos. Hb P O2 Sat P PBS P Genes (within 10kb) Genes (within 100kb) 
PBS O2 Sat rs619660 3 43002953 7.00E-02 1.70E-02 3.60E-06 LOC72985 C3orf39,ZNF662,CCBP2 
PBS O2 Sat rs9853065 3 1.74E+08 3.80E-01 2.70E-02 9.10E-06   
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Table S26. 20 SNPs with largest high altitude Amhara PBS or MR and Hb or O2 sat association pvalue < 0.05 within HA Amhara. 
 
Test 1 Test 2 SNP Chr Nt. pos. Hb P O2 Sat P Genes (within 10kb) Genes (within 100kb) 
PBS O2 Sat rs7753021 6 145310595 9.50E-01 5.40E-03   UTRN 
PBS O2 Sat rs1983521 14 21688320 6.70E-01 3.50E-02     
PBS Hb rs16940947 18 20533441 2.70E-02 5.30E-01     
MR Hb rs926130 21 15136788 8.66E-03 5.67E-01   
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Table S27. 20 SNPs with largest high altitude Amhara MR score. 
SNP Chr Nt. pos. Rank Genes (within 10kb) Genes (within 100kb) 
rs682600 1 199730648 14 CSRP1 PHLDA3,LOC376693,TNNI1,LAD1 
rs6810492 4 11833486 18   
rs2660343 4 41672523 15 WDR21B TMEM33,SLC30A9 
rs2660342 4 41672561 8 WDR21B TMEM33,SLC30A9 
rs12510722 4 100366124 4 ADH6 ADH1A,ADH1B,ADH4 
rs2173199 4 100390402 5  ADH1A,ADH1B,ADH1C,ADH6 
rs6532814 4 100392991 6  ADH1A,ADH1B,ADH1C,ADH6 
rs1826909 4 100436766 19 ADH1A,ADH1B ADH1C,ADH6 
rs13103321 4 100439263 12 ADH1A,ADH1B ADH1C,ADH6 
rs1353621 4 100460598 9 ADH1B ADH1C,ADH1A,ADH7 
rs7661978 4 100503222 10  ADH1B,ADH1C,ADH7,ADH1A 
rs729147 4 100552290 2 ADH7 ADH1C,C4orf17,ADH1B 
rs325502 5 104036032 7   
rs2662891 7 85327629 1   
rs1994056 8 3610422 11 CSMD1  
rs1412060 9 121329170 20   
rs4842631 12 87450918 13 KITLG  
rs9323043 14 40618377 3   
rs8091228 18 69134448 16   
rs926130 21 15136788 17     
Only SNPs with imputation accuracy > 0.9 were tested.
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Table S28. 40 CpG sites with highest high versus low methylation difference within Oromo. TSS 
denotes transcription start site. 
CpG Chr Nt. pos. P Rank Distance to TSS Genes 
cg04286933 22 37802689 2.69E-07 1 393 APOBEC3G 
cg22198623 16 55259369 7.18E-07 2 109 MT1G 
cg14056644 4 111778554 1.27E-06 3 597 PITX2 
cg09931793 9 113130082 1.54E-06 4 452 OR2K2 
cg15089487 15 68972306 1.95E-06 5 499 THAP10 
cg14785479 22 19122535 6.52E-06 6 389 SCARF2 
cg20988728 22 30018502 8.99E-06 7 28 MGC17330 
cg07200897 3 123995511 9.24E-06 8 171 HSPBAP1 
cg07426848 1 151788336 9.63E-06 9 22 S100A3 
cg11237738 4 5578196 1.06E-05 10 412 C4orf6 
cg24237576 16 2225776 1.08E-05 11 693 DNASE1L2 
cg13006591 4 38508060 1.20E-05 12 505 TLR6 
cg21053015 22 38076000 1.25E-05 13 100 SYNGR1 
cg03533858 1 2314256 1.46E-05 14 1403 MORN1 
cg02592124 2 202811724 1.96E-05 15 157 SUMO1 
cg10313633 11 44929466 2.55E-05 16 456 TP53I11 
cg10574499 16 66476255 2.65E-05 17 27 UNQ2446 
cg18410627 9 128717703 2.88E-05 18 829 RALGPS1 
cg15983520 8 145699914 2.93E-05 19 317 GPT 
cg26856388 7 64975330 3.11E-05 20 362 VKORC1L1 
cg13210534 11 111289538 3.52E-05 21 829 HSPB2 
cg08611714 17 36877384 3.55E-05 22 220 KRTHA2 
cg04081402 22 29333587 4.07E-05 23 426 TCN2 
cg24585690 5 135259413 4.10E-05 24 2 IL9 
cg17043155 2 75727427 4.15E-05 25 7 MRPL19 
cg22036988 3 142253035 4.33E-05 26 91 SPSB4 
cg10525372 6 112482026 4.40E-05 27 55 WISP3 
cg19464252 16 30582734 4.43E-05 28 1155 FBS1 
cg21830413 10 70554257 4.47E-05 29 295 VPS26 
cg05670596 3 46423500 4.84E-05 30 225 CCRL2 
cg00795812 2 242450682 5.78E-05 31 951 PDCD1 
cg18168989 9 76834070 5.90E-05 32 940 C9orf41 
cg17964955 10 48010942 5.93E-05 33 55 RBP3 
cg10150813 4 25474276 5.94E-05 34 734 KIAA0746 
cg08859675 19 10424771 6.09E-05 35 134 PDE4A 
cg22396755 1 21867684 6.16E-05 36 702 RAP1GA1 
cg22858308 6 143137306 6.69E-05 37 369 HIVEP2 
cg06852744 7 44109498 6.73E-05 38 987 AEBP1 
cg13439730 16 31054500 7.23E-05 39 152 PRSS8 
cg15901783 13 76359427 7.51E-05 40 901 KCTD12 
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Table S29. 40 CpG sites with highest high versus low methylation difference within Amhara. TSS 
denotes transcription start site. 
CpG Chr Nt. pos. P Rank Distance to TSS Genes 
cg16351002 10 124600091 8.13E-06 1 208 CUZD1 
cg11378686 6 43444256 4.32E-05 2 903 ZNF318 
cg05244766 11 67107075 8.03E-05 3 787 GSTP1 
cg22445920 5 150663371 1.38E-04 4 149 SLC36A3 
cg12026956 5 72147764 2.03E-04 5 490 TNPO1 
cg08385610 8 20156963 2.23E-04 6 120 LZTS1 
cg10453758 3 133862880 2.50E-04 7 1264 ACAD11 
cg19764399 13 47567117 2.81E-04 8 124 MED4 
cg00922727 6 109521816 3.18E-04 9 154 SESN1 
cg23364287 3 48729780 3.99E-04 10 70 IHPK2 
cg04609640 1 45026679 4.21E-04 11 715 VMD2L2 
cg23743114 17 31352509 4.83E-04 12 616 CCL15 
cg27626899 15 89276929 5.27E-04 13 149 HDDC3 
cg23323879 15 63291587 5.85E-04 14 723 CILP 
cg16746462 5 96296194 6.36E-04 15 908 LNPEP 
cg07246225 2 144994129 6.50E-04 16 257 ZFHX1B 
cg05449607 6 111386305 6.78E-04 17 151 C6orf51 
cg10167296 1 204747251 7.16E-04 18 251 RASSF5 
cg10051054 1 3659032 7.66E-04 19 210 CCDC27 
cg23487586 16 83873424 8.29E-04 20 641 MGC22001 
cg09450020 7 89679371 8.31E-04 21 435 STEAP2 
cg21850254 19 42651693 8.43E-04 22 129 ZNF570 
cg08866753 1 39814648 8.66E-04 23 355 PABPC4 
cg00600684 10 122600148 8.71E-04 24 537 BRWD2 
cg05028306 4 17187761 8.95E-04 25 264 LAP3 
cg09180926 15 89338658 9.11E-04 26 150 PRC1 
cg04868764 15 38924311 9.17E-04 27 773 SPINT1 
cg13726191 4 15549131 9.20E-04 28 62 FGFBP1 
cg08303146 11 2423231 9.71E-04 29 NA KCNQ1 
cg18493238 10 37454267 1.00E-03 30 524 ANKRD30A 
cg02449978 3 48205171 1.01E-03 31 366 CDC25A 
cg03077492 5 43448852 1.02E-03 32 623 CCL28 
cg24134767 11 113350848 1.03E-03 33 272 HTR3A 
cg23863670 5 43447686 1.04E-03 34 543 CCL28 
cg12820481 1 209915383 1.05E-03 35 207 NEK2 
cg07123548 19 45588003 1.09E-03 36 69 HIPK4 
cg16791508 12 51001958 1.13E-03 37 520 KRTHB3 
cg09126273 12 15367034 1.17E-03 38 NA PTPRO 
cg07710481 13 87123385 1.21E-03 39 514 SLITRK5 
cg16961218 18 74930131 1.24E-03 40 254 ATP9B 
 
